cAMP信号通路介导全麻药遗忘和睡眠损害效应
|
摘要
背景：
环磷酸腺苷（cAMP或cyclic AMP，3'-5'-cyclic adenosine monophosphate）作为胞内第二信使，主要负责传递G蛋白偶联受体（GPCR，G-protein coupled receptor）信号。cAMP由腺苷酸环化酶（AC，adenylyl cyclase）分解ATP产生，通过磷酸二酯酶（PDE，phosphodiesterase）降解。在中枢神经系统，cAMP能够通过蛋白激酶A（PKA，protein kinase A）-cAMP反应元件结合蛋白（CREB，cAMP responseelement-binding protein）、环核苷酸控制的离子通道（CGN channels， cyclicnucleotide-gated channels，特别是超极化激活的CGN通道（HCN通道，hyperpolarization-activated CGN channels））和cAMP活化的交换蛋白（Epac，exchangeprotein directly activated by cAMP）等信号通路，参与学习记忆、睡眠和昼夜节律调控等多种功能。静脉全麻药异丙酚和吸入性全麻药异氟烷和七氟烷均能够调节中枢和外周GPCR/G蛋白/cAMP信号通路。本课题拟研究调控脑cAMP信号通路对全麻药导致的遗忘和睡眠损害效应的影响。
第一部分cAMP/CREB通路介导异丙酚对空间记忆巩固的损害
目的：
静脉全麻药异丙酚（propofol）在低于麻醉浓度时，即可损害情景记忆的巩固，导致顺行性遗忘，而对记忆编码和短时记忆无明显影响。情景记忆为人类独有，包含了事件（what）、时间（when）、地点（where）、情绪（emotion）和背景环境（context）等要素。大鼠空间记忆模型（Morris水迷宫，non-cued MWM）能够模拟情景记忆的事件和地点要素，被称为“类情景记忆”（episodic-like memory）。本研究假设一：与临床研究相似，镇静剂量的异丙酚能够选择性损害大鼠空间记忆巩固，而对空间学习和短时记忆无影响。已有研究发现，大鼠空间记忆的巩固依赖于海马cAMP/CREB信使系统。假设二：异丙酚损害空间记忆巩固的同时，抑制了海马cAMP/CREB通路。假设三：选择性磷酸二酯酶-4（PDE-4）抑制剂rolipram能够通过抵消异丙酚对cAMP/CREB通路的抑制，逆转异丙酚的遗忘效应。
方法：
实验分为四组：C（赋形剂对照组）；P（异丙酚组，25mg/kg，腹腔注射）；R（rolipram组，0.3mg/kg，腹腔注射）；R+P（rolipram联合异丙酚组，异丙酚注射前25分钟注射rolipram）。实验一：为排除异丙酚和rolipram的镇静效应对异丙酚遗忘的影响，分别在异丙酚注射后5、15和25分钟测定了大鼠的镇静/麻醉评分。实验二：为排除运动能力对异丙酚遗忘的影响，分别在异丙酚注射后5、15和25分钟，采用转棒实验测定了大鼠的运动技巧和协调能力。实验三：为排除非空间因素（运动能力、恐惧感、工作记忆等）对大鼠空间记忆和异丙酚遗忘的影响，在异丙酚注射后5分钟和24小时实施显露平台的水迷宫实验（cued MWM）。实验四：空间学习记忆实验（non-cued MWM）和cAMP/CREB通路活化情况测定。在异丙酚注射后5分钟行定位航行训练（隐藏平台实验），测定空间学习和短时空间记忆情况；在异丙酚注射后24小时，行空间探索实验，测定长时间记忆水平，以反映空间记忆巩固情况。在异丙酚注射后5分钟、50分钟和24小时测定海马cAMP/CREB通路活化情况，包括cAMP水平；ERK1/2、AKT、CaMKII和CREB磷酸化活化程度；CaMKIV、BDNF、c-Fos和Arc蛋白表达水平。
结果：
实验一：与对照组相比，异丙酚25mg/kg注射后，大鼠表现出部分镇静效应。rolipram预注射对异丙酚的镇静效应无影响。实验二：异丙酚和rolipram均不损害大鼠的运动能力。实验三：异丙酚对非空间记忆无影响。异丙酚注射后5分钟和24小时的显露平台实验中，各组大鼠潜伏期无统计学差异。实验四：异丙酚不损害空间学习和短时记忆能力，但损害空间记忆巩固。预先注射rolipram能够对抗异丙酚的遗忘效应。与对照组相比，异丙酚注射后海马cAMP水平降低，CREB和CaMKII磷酸化水平降低，BDNF、Arc蛋白表达下降。单独注射rolipram增加cAMP水平，但对空间记忆和其他信号通路无影响。预先注射rolipram能够对抗异丙酚对cAMP/CREB通路的抑制。
结论：
异丙酚选择性损害空间记忆巩固，导致顺行性遗忘。cAMP/CREB通路可能介导了异丙酚的遗忘效应。
第二部分RGS/Gα_(i2)/cAMP通路介导吸入性全麻药对睡眠的损害
目的：
术后睡眠障碍的发生率约为100%，主要表现为清醒次数增加，NREM睡眠时间减少，REM睡眠时间先抑制后反跳性增加，且伴随有严重的昼夜节律紊乱。术后睡眠障碍严重影响手术疗效，增加术后并发症和死亡率。研究发现，全麻药可能是术后睡眠障碍的独立危险因素。不同于异丙酚，吸入性麻醉药麻醉后，小鼠REM睡眠反跳性增加。研究全麻药导致睡眠障碍的相关机制，并探索相关的有效干预措施，可能有助于改善患者术后预后。不同于静脉麻醉药，异氟烷和七氟烷能够作用于Gα_(i2)/cAMP通路。RGS蛋白（regulators of G protein signaling protein）作为GPCR信号通路的负向调节因子，能够通过加速降解GTP，抑制Gα_(i2)/cAMP通路。此前研究发现RGS蛋白失敏感的Gα_(i2)~(G184S)小鼠对异氟烷更加敏感。异氟烷麻醉后，该基因敲入小鼠翻正反射消失的时间缩短，恢复时间延长。本研究进一步假设一：RGS蛋白对Gα_(i2)/cAMP通路的抑制有助于维持正常的睡眠结构；假设二：RGS蛋白对Gα_(i2)/cAMP通路的抑制参与了吸入麻醉导致的睡眠障碍。
方法：
研究采用了基因敲入（gene knock-in）的Gα_(i2)~(G184S)小鼠。该小鼠Gα_(i2)蛋白第184位甘氨酸残基（G）被突变为丝氨酸残基（S）后，失去与RGS蛋白结合的能力，导致RGS蛋白催化活化型GTP-Gα_(i2)转变为非活化型GDP-Gα_(i2)的作用消失，即RGS失敏感的Gα_(i2)亚单位~(G184S)等位基因突变（RGS-insensitive~(G184S) Gα_(i2)allele mutation）。Gα_(i2)~(G184S)基因敲入小鼠的Gα_(i2)相关信号通路增强，即Gα_(i2)持续抑制cAMP水平和Gβγ信号通路持续活化。实验一测定了野生型（WT）、杂合子Gα_(i2)~(G184S)基因敲入小鼠（+/GS）和纯合子基因敲入小鼠（GS/GS）的24小时基础睡眠结构，以确定RGS/Gα_(i2)相互作用在维持正常睡眠中的作用。实验二观察给予3小时异氟烷（1.3%）或七氟烷（2.8%）麻醉后18.5小时内，三种基因型小鼠的睡眠结构损害情况，以确定RGS/Gα_(i2)是否参与了吸入性麻醉药导致的睡眠紊乱。
结果：
实验一：WT小鼠和+/GS小鼠在24小时觉醒时间、NREM睡眠时间和REM睡眠时间无统计学差异。与WT小鼠相比，纯合子GS/GS小鼠24小时NREM睡眠时间增加了13.95%，而觉醒时间减少了11.85%。WT和GS/GS小鼠的觉醒/睡眠时间比例也不相同。与WT小鼠相比，GS/GS小鼠白昼时NREM睡眠和REM睡眠减少，而夜晚时NREM睡眠和REM睡眠增加。同时，GS/GS小鼠的NREM睡眠和觉醒维持存在障碍，表现为NREM睡眠和觉醒次数增加而平均每次持续时间下降。FFT功率密度谱分析发现，GS/GS小鼠觉醒和NREM睡眠期delta活动（0.5-4Hz）增加，而REM睡眠期theta活动（5-8Hz）减少。以上结果提示RGS/Gα_(i2)参与了小鼠正常睡眠结构的维持。实验二：与对照组（纯氧组）相比，异氟烷或七氟烷麻醉导致了深度睡眠结构紊乱，主要表现为觉醒时间先增加后减少，NREM睡眠时间先减少后增加和REM睡眠反跳性增加。异氟烷或七氟烷麻醉时，WT小鼠恢复正常睡眠所需时间长于GS/GS小鼠。NREM睡眠期delta活动减少仅发生于WT和+/GS小鼠，而非GS/GS小鼠。以上结果提示RGS/Gα_(i2)参与了吸入性全麻药导致的睡眠结构损害。
结论：
RGS/Gα_(i2)/cAMP通路参与了小鼠正常睡眠的维持，并部分介导了异氟烷和七氟烷吸入导致的睡眠障碍。
Background:
Cyclic adenosine monophosphate (cAMP, cyclic AMP or3'-5'-cyclic adenosinemonophosphate) is an intracellular second messenger of G-protein coupled receptor(GPCR) signaling. cAMP is synthesized from ATP by adenylyl cyclase (AC) which isactivated by stimulatory G (Gs)-protein-coupled receptors and inhibited by inhibitory G(Gi)-protein-coupled receptors. It’s decomposition into AMP relies on thephosphodiesterase (PDE). In the central nervous system, cAMP regulates the followingthree main pathways: the protein kinase A (PKA)-CREB (cAMP response element-bindingprotein) pathway, the cyclic nucleotide-gated channels (CNG channels, especially thehyperpolarization-activated CGN channels, HCN channels) pathway and exchangeproteins activated by cAMP (Epac) pathway. GPCR/G protein/cAMP signaling is found toparticipate in the actions of both intravenous anesthetics (for example propofol) andinhaled anesthetics (for example isoflurane and sevoflurane). We intend to investigate therole of cAMP in general anesthetics-induced amnesia and sleep disorder in the currentstudy.
Section1: Rescue of cAMP/CREB signaling reversed spatial memory retentionimpairments induced by subanesthetic dose of propofol
Objective：
The intravenous anesthetic propofol causes episodic memory impairments independent ofsedation and unconsciousness in human. Episodic memory is the human-unique memory ofautobiographical events (what) which occurs in specified time (when) and place (where)and is mixed with emotion and other contextual knowledge (context). The non-cued MorrisWater Maze (MWM) is a hippocampus dependent “episodic-like memory” training taskthat gives information on “what-where” elements. We hypothesized that propofol causedepisodic-like spatial memory retention but not acquisition impairments in rats. Theimpaired memory consolidation was accompanied with reduced hippocampalcAMP/CREB signaling. Furthermore, rescuing cAMP/CREB signaling using selectivephosphodiesterase-4inhibitor rolipram could reverse propofol-induced amnesia andcAMP/CREB signaling inhibition.
Methods：
Male Sprague-Dawley rats were randomized into four groups: vehicle control (C);propofol (P,25mg/kg, intraperitoneal); rolipram (R) and rolipram+propofol (R+P,pretreatment of rolipram25minutes before propofol,0.3mg/kg, intraperitoneal). Sedationand motor coordination were evaluated5,15and25minutes after propofol injection toresist the possibility that inefficient learning and memory after propofol injection duringthe non-Cued MWM was due to sedation and sedation-caused motor incoordination.MWM spatial navigation training (memory acquisition) and probe test (memory retention)were performed5minutes and24hours after propofol injection. Visible cued MWMtraining was simultaneously performed to exclude non-spatial effects. Hippocampal CREBsignaling including cAMP levels; ERK1/2, CaMKII and CREB phosphorylation;CaMKIV, BDNF, c-Fos and Arc protein expression were detected5minutes,50minutesand24hours after propofol administration.
Result：
Rolipram did not change propofol-induced anesthetic/sedative states. Both propofol androlipram did not impair motor skills evaluated by accelerated rotarod tests. No differencewas found on the latency to the platform during the visible MWM. Propofol impairedspatial memory retention but not acquisition in the non-cued MWM. Rolipram alone didnot change non-cued MWM learning and memory consolidation. Pretreatment withrolipram reversed propofol-induced impairments of spatial memory retention andsuppression on cAMP levels, CaMKII and CREB phosphorylation, BDNF and Arcprotein expression.
Conclusion：
Propofol caused spatial memory retention impairments but not acquisition inabilitypossibly by inhibiting cAMP/CREB signaling.
Section2: RGS/Gα_(i2)/cAMP signaling modulated volatile anesthesia-induced sleepdisruptions
Objective:
Postoperative sleep disorders are commonly seen in almost every patient. The changes insleep architecture and circadian rhythms substantially influence surgery effects, causemore complications and are connected with sudden death. Different from intravenousanesthesia, sleep is disrupted after volatile anesthesia with a rebound in REM sleep. Theunderlying mechanisms remain elusive and a better understanding of the relationshipbetween sleep and anesthesia might be useful to help investigate new strategies to improvesleep and facilitate the recovery of surgical patients. Volatile anesthetics but notintravenous anesthetics act on metabotropic, G-protein coupled receptor (GPCR) signaling.GPCR ligands such as acetylcholine, adenosine, serotonin and histamine; GPCRs; effectors(for example cAMP and Gβγ signaling) and regulators all play a role in the benefcial andadverse effects of volatile anesthetics. Regulators of G protein signaling (RGS) proteinsare negative regulators of GPCR signaling and have been shown to modulate the inductionand emergence from isoflurane anesthesia. Specifically, RGS/Gα_(i2)signaling was found tomodulate isoflurane-induced loss of consciousness. The current study further tested thehypothesis that RGS/Gα_(i2)/cAMP signaling modulated normal sleep and disrupted sleepafter isoflurane and sevoflurane anesthesia.
Methods:
Wild-type (WT), heterozygous (+/GS) and homozygous (GS/GS) mice with a geneticablation of RGS action at Gα_(i2)were subjected to electroencephalographic andelectromyographic recordings:1) under ad libitum sleep;2) after3-hour isoflurane (1.3%in pure oxygen) exposure;3) after3-hour sevoflurane (2.8%in pure oxygen) anesthesia.The analogous mutation (Gly184to Ser) prevented the GTPase accelerating protein (GAP)activity of all RGS proteins targeting Gα_(i2), thus downstream Gα_(i2)/cAMP and Gβγ signalingwas enhanced and lasted longer. Sleep architecture (%state; mean episode duration andepisode numbers) and power spectra were collected and analyzed as a function of bothgenotypes and conditions for each time period.
Results:
The homozygous RGS-insensitive (GS/GS) mice showed less wakefulness time (-11.85%)and more NREM sleep time (+13.95%) at baseline compared to the wild-type mice. Thenumbers of NREM sleep and wakefulness episodes were increased and mean episodedurations of NREM sleep and wakefulness were decreased in the GS/GS mice. The GS/GSmice also showed abnormal circadian distribution of sleep and wakefulness. Increasedwakefulness and NREM sleep delta power and decreased REM sleep theta power wereobserved in the GS/GS mice compared to that in the wild-type and+/GS mice. Isofluraneand sevoflurane caused prolonged disruptions of wakefulness, NREM sleep and REMsleep in the wild-type mice. REM sleep changes persisted for more than18.5hours afteranesthesia in the wild-type mice. NREM sleep delta power was also decreased by volatileanesthesia in the wild-type mice. Complete silencing of RGS/Gα_(i2)interaction resulted inless changes in sleep architecture and no changes in power spectra after anesthesia.Recovery of sleep/wake cycle was faster in the GS/GS mice than the wild-type mice.
Conclusions:
RGS/Gα_(i2)interface regulates sleep amount, sleep consolidation and circadian timing ofsleep. Sleep disruptions after volatile anesthesia partially depend on the inhibition of Gα_(i2)signaling by RGS proteins.
环磷酸腺苷（cAMP或cyclic AMP，3'-5'-cyclic adenosine monophosphate）作为胞内第二信使，主要负责传递G蛋白偶联受体（GPCR，G-protein coupled receptor）信号。cAMP由腺苷酸环化酶（AC，adenylyl cyclase）分解ATP产生，通过磷酸二酯酶（PDE，phosphodiesterase）降解。在中枢神经系统，cAMP能够通过蛋白激酶A（PKA，protein kinase A）-cAMP反应元件结合蛋白（CREB，cAMP responseelement-binding protein）、环核苷酸控制的离子通道（CGN channels， cyclicnucleotide-gated channels，特别是超极化激活的CGN通道（HCN通道，hyperpolarization-activated CGN channels））和cAMP活化的交换蛋白（Epac，exchangeprotein directly activated by cAMP）等信号通路，参与学习记忆、睡眠和昼夜节律调控等多种功能。静脉全麻药异丙酚和吸入性全麻药异氟烷和七氟烷均能够调节中枢和外周GPCR/G蛋白/cAMP信号通路。本课题拟研究调控脑cAMP信号通路对全麻药导致的遗忘和睡眠损害效应的影响。
第一部分cAMP/CREB通路介导异丙酚对空间记忆巩固的损害
目的：
静脉全麻药异丙酚（propofol）在低于麻醉浓度时，即可损害情景记忆的巩固，导致顺行性遗忘，而对记忆编码和短时记忆无明显影响。情景记忆为人类独有，包含了事件（what）、时间（when）、地点（where）、情绪（emotion）和背景环境（context）等要素。大鼠空间记忆模型（Morris水迷宫，non-cued MWM）能够模拟情景记忆的事件和地点要素，被称为“类情景记忆”（episodic-like memory）。本研究假设一：与临床研究相似，镇静剂量的异丙酚能够选择性损害大鼠空间记忆巩固，而对空间学习和短时记忆无影响。已有研究发现，大鼠空间记忆的巩固依赖于海马cAMP/CREB信使系统。假设二：异丙酚损害空间记忆巩固的同时，抑制了海马cAMP/CREB通路。假设三：选择性磷酸二酯酶-4（PDE-4）抑制剂rolipram能够通过抵消异丙酚对cAMP/CREB通路的抑制，逆转异丙酚的遗忘效应。
方法：
实验分为四组：C（赋形剂对照组）；P（异丙酚组，25mg/kg，腹腔注射）；R（rolipram组，0.3mg/kg，腹腔注射）；R+P（rolipram联合异丙酚组，异丙酚注射前25分钟注射rolipram）。实验一：为排除异丙酚和rolipram的镇静效应对异丙酚遗忘的影响，分别在异丙酚注射后5、15和25分钟测定了大鼠的镇静/麻醉评分。实验二：为排除运动能力对异丙酚遗忘的影响，分别在异丙酚注射后5、15和25分钟，采用转棒实验测定了大鼠的运动技巧和协调能力。实验三：为排除非空间因素（运动能力、恐惧感、工作记忆等）对大鼠空间记忆和异丙酚遗忘的影响，在异丙酚注射后5分钟和24小时实施显露平台的水迷宫实验（cued MWM）。实验四：空间学习记忆实验（non-cued MWM）和cAMP/CREB通路活化情况测定。在异丙酚注射后5分钟行定位航行训练（隐藏平台实验），测定空间学习和短时空间记忆情况；在异丙酚注射后24小时，行空间探索实验，测定长时间记忆水平，以反映空间记忆巩固情况。在异丙酚注射后5分钟、50分钟和24小时测定海马cAMP/CREB通路活化情况，包括cAMP水平；ERK1/2、AKT、CaMKII和CREB磷酸化活化程度；CaMKIV、BDNF、c-Fos和Arc蛋白表达水平。
结果：
实验一：与对照组相比，异丙酚25mg/kg注射后，大鼠表现出部分镇静效应。rolipram预注射对异丙酚的镇静效应无影响。实验二：异丙酚和rolipram均不损害大鼠的运动能力。实验三：异丙酚对非空间记忆无影响。异丙酚注射后5分钟和24小时的显露平台实验中，各组大鼠潜伏期无统计学差异。实验四：异丙酚不损害空间学习和短时记忆能力，但损害空间记忆巩固。预先注射rolipram能够对抗异丙酚的遗忘效应。与对照组相比，异丙酚注射后海马cAMP水平降低，CREB和CaMKII磷酸化水平降低，BDNF、Arc蛋白表达下降。单独注射rolipram增加cAMP水平，但对空间记忆和其他信号通路无影响。预先注射rolipram能够对抗异丙酚对cAMP/CREB通路的抑制。
结论：
异丙酚选择性损害空间记忆巩固，导致顺行性遗忘。cAMP/CREB通路可能介导了异丙酚的遗忘效应。
第二部分RGS/Gα_(i2)/cAMP通路介导吸入性全麻药对睡眠的损害
目的：
术后睡眠障碍的发生率约为100%，主要表现为清醒次数增加，NREM睡眠时间减少，REM睡眠时间先抑制后反跳性增加，且伴随有严重的昼夜节律紊乱。术后睡眠障碍严重影响手术疗效，增加术后并发症和死亡率。研究发现，全麻药可能是术后睡眠障碍的独立危险因素。不同于异丙酚，吸入性麻醉药麻醉后，小鼠REM睡眠反跳性增加。研究全麻药导致睡眠障碍的相关机制，并探索相关的有效干预措施，可能有助于改善患者术后预后。不同于静脉麻醉药，异氟烷和七氟烷能够作用于Gα_(i2)/cAMP通路。RGS蛋白（regulators of G protein signaling protein）作为GPCR信号通路的负向调节因子，能够通过加速降解GTP，抑制Gα_(i2)/cAMP通路。此前研究发现RGS蛋白失敏感的Gα_(i2)~(G184S)小鼠对异氟烷更加敏感。异氟烷麻醉后，该基因敲入小鼠翻正反射消失的时间缩短，恢复时间延长。本研究进一步假设一：RGS蛋白对Gα_(i2)/cAMP通路的抑制有助于维持正常的睡眠结构；假设二：RGS蛋白对Gα_(i2)/cAMP通路的抑制参与了吸入麻醉导致的睡眠障碍。
方法：
研究采用了基因敲入（gene knock-in）的Gα_(i2)~(G184S)小鼠。该小鼠Gα_(i2)蛋白第184位甘氨酸残基（G）被突变为丝氨酸残基（S）后，失去与RGS蛋白结合的能力，导致RGS蛋白催化活化型GTP-Gα_(i2)转变为非活化型GDP-Gα_(i2)的作用消失，即RGS失敏感的Gα_(i2)亚单位~(G184S)等位基因突变（RGS-insensitive~(G184S) Gα_(i2)allele mutation）。Gα_(i2)~(G184S)基因敲入小鼠的Gα_(i2)相关信号通路增强，即Gα_(i2)持续抑制cAMP水平和Gβγ信号通路持续活化。实验一测定了野生型（WT）、杂合子Gα_(i2)~(G184S)基因敲入小鼠（+/GS）和纯合子基因敲入小鼠（GS/GS）的24小时基础睡眠结构，以确定RGS/Gα_(i2)相互作用在维持正常睡眠中的作用。实验二观察给予3小时异氟烷（1.3%）或七氟烷（2.8%）麻醉后18.5小时内，三种基因型小鼠的睡眠结构损害情况，以确定RGS/Gα_(i2)是否参与了吸入性麻醉药导致的睡眠紊乱。
结果：
实验一：WT小鼠和+/GS小鼠在24小时觉醒时间、NREM睡眠时间和REM睡眠时间无统计学差异。与WT小鼠相比，纯合子GS/GS小鼠24小时NREM睡眠时间增加了13.95%，而觉醒时间减少了11.85%。WT和GS/GS小鼠的觉醒/睡眠时间比例也不相同。与WT小鼠相比，GS/GS小鼠白昼时NREM睡眠和REM睡眠减少，而夜晚时NREM睡眠和REM睡眠增加。同时，GS/GS小鼠的NREM睡眠和觉醒维持存在障碍，表现为NREM睡眠和觉醒次数增加而平均每次持续时间下降。FFT功率密度谱分析发现，GS/GS小鼠觉醒和NREM睡眠期delta活动（0.5-4Hz）增加，而REM睡眠期theta活动（5-8Hz）减少。以上结果提示RGS/Gα_(i2)参与了小鼠正常睡眠结构的维持。实验二：与对照组（纯氧组）相比，异氟烷或七氟烷麻醉导致了深度睡眠结构紊乱，主要表现为觉醒时间先增加后减少，NREM睡眠时间先减少后增加和REM睡眠反跳性增加。异氟烷或七氟烷麻醉时，WT小鼠恢复正常睡眠所需时间长于GS/GS小鼠。NREM睡眠期delta活动减少仅发生于WT和+/GS小鼠，而非GS/GS小鼠。以上结果提示RGS/Gα_(i2)参与了吸入性全麻药导致的睡眠结构损害。
结论：
RGS/Gα_(i2)/cAMP通路参与了小鼠正常睡眠的维持，并部分介导了异氟烷和七氟烷吸入导致的睡眠障碍。
Background:
Cyclic adenosine monophosphate (cAMP, cyclic AMP or3'-5'-cyclic adenosinemonophosphate) is an intracellular second messenger of G-protein coupled receptor(GPCR) signaling. cAMP is synthesized from ATP by adenylyl cyclase (AC) which isactivated by stimulatory G (Gs)-protein-coupled receptors and inhibited by inhibitory G(Gi)-protein-coupled receptors. It’s decomposition into AMP relies on thephosphodiesterase (PDE). In the central nervous system, cAMP regulates the followingthree main pathways: the protein kinase A (PKA)-CREB (cAMP response element-bindingprotein) pathway, the cyclic nucleotide-gated channels (CNG channels, especially thehyperpolarization-activated CGN channels, HCN channels) pathway and exchangeproteins activated by cAMP (Epac) pathway. GPCR/G protein/cAMP signaling is found toparticipate in the actions of both intravenous anesthetics (for example propofol) andinhaled anesthetics (for example isoflurane and sevoflurane). We intend to investigate therole of cAMP in general anesthetics-induced amnesia and sleep disorder in the currentstudy.
Section1: Rescue of cAMP/CREB signaling reversed spatial memory retentionimpairments induced by subanesthetic dose of propofol
Objective：
The intravenous anesthetic propofol causes episodic memory impairments independent ofsedation and unconsciousness in human. Episodic memory is the human-unique memory ofautobiographical events (what) which occurs in specified time (when) and place (where)and is mixed with emotion and other contextual knowledge (context). The non-cued MorrisWater Maze (MWM) is a hippocampus dependent “episodic-like memory” training taskthat gives information on “what-where” elements. We hypothesized that propofol causedepisodic-like spatial memory retention but not acquisition impairments in rats. Theimpaired memory consolidation was accompanied with reduced hippocampalcAMP/CREB signaling. Furthermore, rescuing cAMP/CREB signaling using selectivephosphodiesterase-4inhibitor rolipram could reverse propofol-induced amnesia andcAMP/CREB signaling inhibition.
Methods：
Male Sprague-Dawley rats were randomized into four groups: vehicle control (C);propofol (P,25mg/kg, intraperitoneal); rolipram (R) and rolipram+propofol (R+P,pretreatment of rolipram25minutes before propofol,0.3mg/kg, intraperitoneal). Sedationand motor coordination were evaluated5,15and25minutes after propofol injection toresist the possibility that inefficient learning and memory after propofol injection duringthe non-Cued MWM was due to sedation and sedation-caused motor incoordination.MWM spatial navigation training (memory acquisition) and probe test (memory retention)were performed5minutes and24hours after propofol injection. Visible cued MWMtraining was simultaneously performed to exclude non-spatial effects. Hippocampal CREBsignaling including cAMP levels; ERK1/2, CaMKII and CREB phosphorylation;CaMKIV, BDNF, c-Fos and Arc protein expression were detected5minutes,50minutesand24hours after propofol administration.
Result：
Rolipram did not change propofol-induced anesthetic/sedative states. Both propofol androlipram did not impair motor skills evaluated by accelerated rotarod tests. No differencewas found on the latency to the platform during the visible MWM. Propofol impairedspatial memory retention but not acquisition in the non-cued MWM. Rolipram alone didnot change non-cued MWM learning and memory consolidation. Pretreatment withrolipram reversed propofol-induced impairments of spatial memory retention andsuppression on cAMP levels, CaMKII and CREB phosphorylation, BDNF and Arcprotein expression.
Conclusion：
Propofol caused spatial memory retention impairments but not acquisition inabilitypossibly by inhibiting cAMP/CREB signaling.
Section2: RGS/Gα_(i2)/cAMP signaling modulated volatile anesthesia-induced sleepdisruptions
Objective:
Postoperative sleep disorders are commonly seen in almost every patient. The changes insleep architecture and circadian rhythms substantially influence surgery effects, causemore complications and are connected with sudden death. Different from intravenousanesthesia, sleep is disrupted after volatile anesthesia with a rebound in REM sleep. Theunderlying mechanisms remain elusive and a better understanding of the relationshipbetween sleep and anesthesia might be useful to help investigate new strategies to improvesleep and facilitate the recovery of surgical patients. Volatile anesthetics but notintravenous anesthetics act on metabotropic, G-protein coupled receptor (GPCR) signaling.GPCR ligands such as acetylcholine, adenosine, serotonin and histamine; GPCRs; effectors(for example cAMP and Gβγ signaling) and regulators all play a role in the benefcial andadverse effects of volatile anesthetics. Regulators of G protein signaling (RGS) proteinsare negative regulators of GPCR signaling and have been shown to modulate the inductionand emergence from isoflurane anesthesia. Specifically, RGS/Gα_(i2)signaling was found tomodulate isoflurane-induced loss of consciousness. The current study further tested thehypothesis that RGS/Gα_(i2)/cAMP signaling modulated normal sleep and disrupted sleepafter isoflurane and sevoflurane anesthesia.
Methods:
Wild-type (WT), heterozygous (+/GS) and homozygous (GS/GS) mice with a geneticablation of RGS action at Gα_(i2)were subjected to electroencephalographic andelectromyographic recordings:1) under ad libitum sleep;2) after3-hour isoflurane (1.3%in pure oxygen) exposure;3) after3-hour sevoflurane (2.8%in pure oxygen) anesthesia.The analogous mutation (Gly184to Ser) prevented the GTPase accelerating protein (GAP)activity of all RGS proteins targeting Gα_(i2), thus downstream Gα_(i2)/cAMP and Gβγ signalingwas enhanced and lasted longer. Sleep architecture (%state; mean episode duration andepisode numbers) and power spectra were collected and analyzed as a function of bothgenotypes and conditions for each time period.
Results:
The homozygous RGS-insensitive (GS/GS) mice showed less wakefulness time (-11.85%)and more NREM sleep time (+13.95%) at baseline compared to the wild-type mice. Thenumbers of NREM sleep and wakefulness episodes were increased and mean episodedurations of NREM sleep and wakefulness were decreased in the GS/GS mice. The GS/GSmice also showed abnormal circadian distribution of sleep and wakefulness. Increasedwakefulness and NREM sleep delta power and decreased REM sleep theta power wereobserved in the GS/GS mice compared to that in the wild-type and+/GS mice. Isofluraneand sevoflurane caused prolonged disruptions of wakefulness, NREM sleep and REMsleep in the wild-type mice. REM sleep changes persisted for more than18.5hours afteranesthesia in the wild-type mice. NREM sleep delta power was also decreased by volatileanesthesia in the wild-type mice. Complete silencing of RGS/Gα_(i2)interaction resulted inless changes in sleep architecture and no changes in power spectra after anesthesia.Recovery of sleep/wake cycle was faster in the GS/GS mice than the wild-type mice.
Conclusions:
RGS/Gα_(i2)interface regulates sleep amount, sleep consolidation and circadian timing ofsleep. Sleep disruptions after volatile anesthesia partially depend on the inhibition of Gα_(i2)signaling by RGS proteins.
引文
1. Alkire MT, Hudetz AG, Tononi G: Consciousness and anesthesia. Science2008;322:876-80
2. Veselis RA: Memory: a guide for anaesthetists. Best Pract Res Clin Anaesthesiol2007;21:297-312
3. Veselis RA, Pryor KO, Reinsel RA, Mehta M, Pan H, Johnson R, Jr.: Low-dose propofol-inducedamnesia is not due to a failure of encoding: left inferior prefrontal cortex is still active. Anesthesiology2008;109:213-24
4. Deeprose C, Andrade J, Varma S, Edwards N: Unconscious learning during surgery with propofolanaesthesia. Br J Anaesth2004;92:171-7
5. Beracochea D: Anterograde and retrograde effects of benzodiazepines on memory.ScientificWorldJournal2006;6:1460-5
6. Wang DS, Orser BA: Inhibition of learning and memory by general anesthetics. Can J Anaesth2011;58:167-77
7. Pryor KO, Reinsel RA, Mehta M, Li Y, Wixted JT, Veselis RA: Visual P2-N2complex and arousalat the time of encoding predict the time domain characteristics of amnesia for multiple intravenousanesthetic drugs in humans. Anesthesiology2010;113:313-26
8. Veselis RA, Reinsel RA, Feshchenko VA, Johnson R, Jr.: Information loss over time defines thememory defect of propofol: a comparative response with thiopental and dexmedetomidine.Anesthesiology2004;101:831-41
9. Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson R, Jr.: Propofol and midazolam inhibitconscious memory processes very soon after encoding: an event-related potential study of familiarityand recollection in volunteers. Anesthesiology2009;110:295-312
10. Alkire MT, Vazdarjanova A, Dickinson-Anson H, White NS, Cahill L: Lesions of the basolateralamygdala complex block propofol-induced amnesia for inhibitory avoidance learning in rats.Anesthesiology2001;95:708-15
11. Ren Y, Zhang FJ, Xue QS, Zhao X, Yu BW: Bilateral inhibition of gamma-aminobutyric acid typeA receptor function within the basolateral amygdala blocked propofol-induced amnesia andactivity-regulated cytoskeletal protein expression inhibition in the hippocampus. Anesthesiology2008;109:775-81
12. D'Hooge R, De Deyn PP: Applications of the Morris water maze in the study of learning andmemory. Brain Res Brain Res Rev2001;36:60-90
13. Crystal JD: Episodic-like memory in animals. Behav Brain Res2010;215:235-43
14. Vorhees CV, Williams MT: Morris water maze: procedures for assessing spatial and related formsof learning and memory. Nat Protoc2006;1:848-58
15. Neves G, Cooke SF, Bliss TV: Synaptic plasticity, memory and the hippocampus: a neural networkapproach to causality. Nat Rev Neurosci2008;9:65-75
16. Alkire MT, Guzowski JF: Hypothesis: suppression of memory protein formation underliesanesthetic-induced amnesia. Anesthesiology2008;109:768-70
17. Gold PE: The many faces of amnesia. Learn Mem2006;13:506-14
18. Alberini CM: Transcription factors in long-term memory and synaptic plasticity. Physiol Rev2009;89:121-45
19. Barco A, Marie H: Genetic approaches to investigate the role of CREB in neuronal plasticity andmemory. Mol Neurobiol2011;44:330-49
20. Florian C, Mons N, Roullet P: CREB antisense oligodeoxynucleotide administration into the dorsalhippocampal CA3region impairs long-but not short-term spatial memory in mice. Learn Mem2006;13:465-72
21. Nguyen PV: CREB and the enhancement of long-term memory. Trends Neurosci2001;24:314
22. Kandel ER: The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB.Mol Brain2012;5:14
23. Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura M, Takemoto-KimuraS, Worley PF, Bito H: Synaptic activity-responsive element in the Arc/Arg3.1promoter essential forsynapse-to-nucleus signaling in activated neurons. Proc Natl Acad Sci U S A2009;106:316-21
24. Fibuch EE, Wang JQ: Inhibition of the MAPK/ERK cascade: a potential transcription-dependentmechanism for the amnesic effect of anesthetic propofol. Neurosci Bull2007;23:119-24
25. Kozinn J, Mao L, Arora A, Yang L, Fibuch EE, Wang JQ: Inhibition of glutamatergic activation ofextracellular signal-regulated protein kinases in hippocampal neurons by the intravenous anestheticpropofol. Anesthesiology2006;105:1182-91
26. Kidambi S, Yarmush J, Berdichevsky Y, Kamath S, Fong W, Schianodicola J: Propofol inducesMAPK/ERK cascade dependant expression of cFos and Egr-1in rat hippocampal slices. BMC ResNotes2010;3:201
27. Cui X, Li J, Li T, Ji F, Bu X, Zhang N, Zhang B: Propofol and ketamine-induced anestheticdepth-dependent decrease of CaMKII phosphorylation levels in rat hippocampus and cortex. JNeurosurg Anesthesiol2009;21:145-54
28. Vutskits L, Lysakowski C, Czarnetzki C, Jenny B, Copin JC, Tramer MR: Plasma concentrationsof brain-derived neurotrophic factor in patients undergoing minor surgery: a randomized controlled trial.Neurochem Res2008;33:1325-31
29. Vecsey CG, Baillie GS, Jaganath D, Havekes R, Daniels A, Wimmer M, Huang T, Brown KM, LiXY, Descalzi G, Kim SS, Chen T, Shang YZ, Zhuo M, Houslay MD, Abel T: Sleep deprivation impairscAMP signalling in the hippocampus. Nature2009;461:1122-5
30. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E: Rolipram, a type IV-specificphosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation andimproves memory. Proc Natl Acad Sci U S A1998;95:15020-5
31. Zhang HT, O'Donnell JM: Phosphodiesterase-4as a pharmacological target mediatingantidepressant and cognitive effects on behavior, Phosphodiesterases in Health and Disease. London,UK, CRC Press,2007, pp539-558
32. Giorgi M, Modica A, Pompili A, Pacitti C, Gasbarri A: The induction of cyclic nucleotidephosphodiesterase4gene (PDE4D) impairs memory in a water maze task. Behav Brain Res2004;154:99-106
33. Krause W, Kuhne G: Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the ratand the rabbit. Studies on species differences. Xenobiotica1988;18:561-71
34. Laalou FZ, de Vasconcelos AP, Oberling P, Jeltsch H, Cassel JC, Pain L: Involvement of the basalcholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology2008;108:888-96
35. Gamou S, Fukuda S, Ogura M, Sakamoto H, Morita S: Microinjection of propofol into theperifornical area induces sedation with decreasing cortical acetylcholine release in rats. Anesth Analg2010;111:395-402
36. Feldman LA, Shapiro ML, Nalbantoglu J: A novel, rapidly acquired and persistent spatial memorytask that induces immediate early gene expression. Behav Brain Funct2010;6:35
37. Ward CP, McCarley RW, Strecker RE: Experimental sleep fragmentation impairs spatial referencebut not working memory in Fischer/Brown Norway rats. J Sleep Res2009;18:238-44
38. Quan HX, Jin JY, Wen JF, Cho KW:[beta]1-Adrenergic receptor activation decreases ANP releasevia cAMP-Ca2+signaling in perfused beating rabbit atria. Life Sciences2010;87:246-253
39. Zu L, He J, Jiang H, Xu C, Pu S, Xu G: Bacterial endotoxin stimulates adipose lipolysis viatoll-like receptor4and extracellular signal-regulated kinase pathway. J Biol Chem2009;284:5915-26
40. Stanley JL, Lincoln RJ, Brown TA, McDonald LM, Dawson GR, Reynolds DS: The mouse beamwalking assay offers improved sensitivity over the mouse rotarod in determining motor coordinationdeficits induced by benzodiazepines. J Psychopharmacol2005;19:221-7
41. Engeland CG, Vanderwolf CH, Gelb AW: Rats show unimpaired learning within minutes afterrecovery from single bolus propofol anesthesia. Can J Anaesth1999;46:586-92
42. Scoville WB, Milner B: Loss of recent memory after bilateral hippocampal lesions. J NeurolNeurosurg Psychiatry1957;20:11-21
43. Wei H, Xiong W, Yang S, Zhou Q, Liang C, Zeng BX, Xu L: Propofol facilitates the developmentof long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1region of the hippocampus of anesthetized rats. Neurosci Lett2002;324:181-4
44. Wang W, Wang H, Gong N, Xu TL: Changes of K+-Cl-cotransporter2(KCC2) and circuitactivity in propofol-induced impairment of long-term potentiation in rat hippocampal slices. Brain ResBull2006;70:444-9
45. Zhang M, Storm DR, Wang H: Bidirectional synaptic plasticity and spatial memory flexibilityrequire Ca2+-stimulated adenylyl cyclases. J Neurosci2011;31:10174-83
46. Kurokawa H, Murray PA, Damron DS: Propofol attenuates beta-adrenoreceptor-mediated signaltransduction via a protein kinase C-dependent pathway in cardiomyocytes. Anesthesiology2002;96:688-98
47. Wang Y, Kikuchi T, Sakai M, Wu JL, Sato K, Okumura F: Age-related modifications of effects ofketamine and propofol on rat hippocampal acetylcholine release studied by in vivo brain microdialysis.Acta Anaesthesiol Scand2000;44:112-7
48. Bernabeu R, Bevilaqua L, Ardenghi P, Bromberg E, Schmitz P, Bianchin M, Izquierdo I, MedinaJH: Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a latememory consolidation phase of aversively motivated learning in rats. Proc Natl Acad Sci U S A1997;94:7041-6
49. Kida S, Josselyn SA, Pena de Ortiz S, Kogan JH, Chevere I, Masushige S, Silva AJ: CREBrequired for the stability of new and reactivated fear memories. Nat Neurosci2002;5:348-55
50. Lu Y, Christian K, Lu B: BDNF: a key regulator for protein synthesis-dependent LTP andlong-term memory? Neurobiol Learn Mem2008;89:312-23
51. Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H: The experimental and clinicalpharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther2008;14:95-106
52. Lawton BK, Brown NJ, Reilly CS, Brookes ZL: Role of L-type calcium channels in alteredmicrovascular responses to propofol in hypertension. Br J Anaesth2012;108:929-35
53. Linnarsson S, Bjorklund A, Ernfors P: Learning deficit in BDNF mutant mice. Eur J Neurosci1997;9:2581-7
54. Montkowski A, Holsboer F: Intact spatial learning and memory in transgenic mice with reducedBDNF. Neuroreport1997;8:779-82
55. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ: Hippocampus-specific deletion of BDNF in adultmice impairs spatial memory and extinction of aversive memories. Mol Psychiatry2007;12:656-70
56. Korb E, Finkbeiner S: Arc in synaptic plasticity: from gene to behavior. Trends Neurosci2011;34:591-8
57. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA:Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenanceof long-term potentiation and the consolidation of long-term memory. J Neurosci2000;20:3993-4001
58. Monti B, Berteotti C, Contestabile A: Subchronic rolipram delivery activates hippocampal CREBand arc, enhances retention and slows down extinction of conditioned fear. Neuropsychopharmacology2006;31:278-86
59. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O: Persistent improvement insynaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest2004;114:1624-34
60. Yu X, Guo L, Yin G, Zong X, Ai Y: Effect of non-specific HCN1blocker CsCl on spatial learningand memory in mouse. J Huazhong Univ Sci Technolog Med Sci2006;26:164-6
61. Grandoch M, Roscioni SS, Schmidt M: The role of Epac proteins, novel cAMP mediators, in theregulation of immune, lung and neuronal function. Br J Pharmacol2010;159:265-84
62. Perez-Torres S, Miro X, Palacios JM, Cortes R, Puigdomenech P, Mengod G: Phosphodiesterasetype4isozymes expression in human brain examined by in situ hybridization histochemistryand[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat2000;20:349-74
63. Ahmed T, Frey JU: Expression of the specific type IV phosphodiesterase gene PDE4B3duringdifferent phases of long-term potentiation in single hippocampal slices of rats in vitro. Neuroscience2003;117:627-38
64. Sanou J, Ilboudo D, Goodall G, Bourdalle-Badie C, Erny P:[Evaluation of cognitive functionsafter anesthesia with propofol]. Ann Fr Anesth Reanim1996;15:1155-61
65. Padmanabhan U, Leslie K, Eer AS, Maruff P, Silbert BS: Early cognitive impairment after sedationfor colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg2009;109:1448-55
66. Collado MC, Beleta J, Martinez E, Miralpeix M, Domenech T, Palacios JM, Hernandez J:Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type4inhibitor. Br J Pharmacol1998;123:1047-54
67. Lydic R, Baghdoyan HA: Sleep, anesthesiology, and the neurobiology of arousal state control.Anesthesiology2005;103:1268-95
68. Mashour GA, Pal D: Interfaces of sleep and anesthesia. Anesthesiol Clin2012;30:385-98
69. Shadan S: Neuroscience: Sleep to oblivion. Nature2012;491:46
70. Moore JT, Chen J, Han B, Meng QC, Veasey SC, Beck SG, Kelz MB: Direct activation ofsleep-promoting VLPO neurons by volatile anesthetics contributes to anesthetic hypnosis. Curr Biol2012;22:2008-16
71. Brown EN, Lydic R, Schiff ND: General anesthesia, sleep, and coma. N Engl J Med2010;363:2638-50
72. Muller CP, Pum ME, Amato D, Schuttler J, Huston JP, Silva MA: The in vivo neurochemistry ofthe brain during general anesthesia. J Neurochem2011;119:419-46
73. Watson CJ, Baghdoyan HA, Lydic R: Neuropharmacology of Sleep and Wakefulness. Sleep MedClin2010;5:513-528
74. Cirelli C, Bushey D, Hill S, Huber R, Kreber R, Ganetzky B, Tononi G: Reduced sleep inDrosophila Shaker mutants. Nature2005;434:1087-92
75. Weber B, Schaper C, Bushey D, Rohlfs M, Steinfath M, Tononi G, Cirelli C, Scholz J, Bein B:Increased volatile anesthetic requirement in short-sleeping Drosophila mutants. Anesthesiology2009;110:313-6
76. Ouyang M, Hellman K, Abel T, Thomas SA: Adrenergic signaling plays a critical role in themaintenance of waking and in the regulation of REM sleep. J Neurophysiol2004;92:2071-82
77. Hu FY, Hanna GM, Han W, Mardini F, Thomas SA, Wyner AJ, Kelz MB: Hypnotichypersensitivity to volatile anesthetics and dexmedetomidine in dopamine beta-hydroxylase knockoutMice. Anesthesiology2012;117:1006-17
78. Icaza EE, Huang X, Fu Y, Neubig RR, Baghdoyan HA, Lydic R: Isoflurane-induced changes inrighting response and breathing are modulated by RGS proteins. Anesth Analg2009;109:1500-5
79. Kain ZN, Mayes LC, Caldwell-Andrews AA, Alexander GM, Krivutza D, Teague BA, Wang SM:Sleeping characteristics of children undergoing outpatient elective surgery. Anesthesiology2002;97:1093-101
80. G genur I, Rosenberg J: Sleep Disturbances after Noncardiac Surgery, Sleep: A ComprehensiveHandbook, John Wiley&Sons, Inc.,2005, pp913-925
81. Gogenur I, Wildschiotz G, Rosenberg J: Circadian distribution of sleep phases after majorabdominal surgery. Br J Anaesth2008;100:45-9
82. Krenk L, Jennum P, Kehlet H: Sleep disturbances after fast-track hip and knee arthroplasty. Br JAnaesth2012;109:769-75
83. Dette F, Cassel W, Urban F, Zoremba M, Koehler U, Wulf H, Graf J, Steinfeldt T: Occurrence ofrapid eye movement sleep deprivation after surgery under regional anesthesia. Anesth Analg2013;116:939-43
84. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV: Sleep deprivation and the control ofventilation. Am Rev Respir Dis1983;128:984-6
85. Knill RL, Skinner MI, Novick T, Vandenberghe HM, Moote CA: The night of intense REM sleepafter anesthesia and surgery increases urinary catecholamines. Can J Anaesth1990;37: S12
86. Rosenberg J, Rasmussen V, von Jessen F, Ullstad T, Kehlet H: Late postoperative episodic andconstant hypoxaemia and associated ECG abnormalities. Br J Anaesth1990;65:684-91
87. Rosenberg J, Wildschiodtz G, Pedersen MH, von Jessen F, Kehlet H: Late postoperative nocturnalepisodic hypoxaemia and associated sleep pattern. Br J Anaesth1994;72:145-50
88. Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J: Postoperative sleep disturbances:mechanisms and clinical implications. Br J Anaesth1996;76:552-9
89. Kotiniemi LH, Ryhanen PT, Moilanen IK: Behavioural changes in children following day-casesurgery: a4-week follow-up of551children. Anaesthesia1997;52:970-6
90. Kushikata T, Yoshida H, Hirota K: Sleep in anesthesiology–What can we learn about anesthesiafrom studying sleep? Trends in Anaesthesia and Critical Care2012;2:30-35
91. Vasu TS, Grewal R, Doghramji K: Obstructive sleep apnea syndrome and perioperativecomplications: a systematic review of the literature. J Clin Sleep Med2012;8:199-207
92. Venkateshiah SB, Collop NA: Sleep and sleep disorders in the hospital. Chest2012;141:1337-45
93. Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y: The usefulness of bright light therapy for patientsafter oesophagectomy. Intensive Crit Care Nurs2011;27:158-66
94. Taguchi T, Yano M, Kido Y: Influence of bright light therapy on postoperative patients: a pilotstudy. Intensive Crit Care Nurs2007;23:289-97
95. Moote CA, Knill RL: Isoflurane anesthesia causes a transient alteration in nocturnal sleep.Anesthesiology1988;69:327-31
96. Steinmetz J, Holm-Knudsen R, Eriksen K, Marxen D, Rasmussen LS: Quality differences inpostoperative sleep between propofol-remifentanil and sevoflurane anesthesia in infants. Anesth Analg2007;104:779-83
97. Tung A, Lynch JP, Mendelson WB: Prolonged sedation with propofol in the rat does not result insleep deprivation. Anesth Analg2001;92:1232-6
98. Mashour GA, Lipinski WJ, Matlen LB, Walker AJ, Turner AM, Schoen W, Lee U, Poe GR:Isoflurane anesthesia does not satisfy the homeostatic need for rapid eye movement sleep. Anesth Analg2010;110:1283-9
99. Pick J, Chen Y, Moore JT, Sun Y, Wyner AJ, Friedman EB, Kelz MB: Rapid eye movement sleepdebt accrues in mice exposed to volatile anesthetics. Anesthesiology2011;115:702-12
100. Tung A, Bergmann BM, Herrera S, Cao D, Mendelson WB: Recovery from sleep deprivationoccurs during propofol anesthesia. Anesthesiology2004;100:1419-26
101. Pal D, Lipinski WJ, Walker AJ, Turner AM, Mashour GA: State-specific effects of sevofluraneanesthesia on sleep homeostasis: selective recovery of slow wave but not rapid eye movement sleep.Anesthesiology2011;114:302-10
102. Jang HS, Jung JY, Jang KH, Lee MG: Effects of isoflurane anesthesia on post-anestheticsleep-wake architectures in rats. Korean J Physiol Pharmacol2010;14:291-7
103. Styer AM, Mirshahi UL, Wang C, Girard L, Jin T, Logothetis DE, Mirshahi T: G Protein βγ GatingConfers Volatile Anesthetic Inhibition to Kir3Channels. Journal of Biological Chemistry2010;285:41290-41299
104. Minami K, Uezono Y: The recent progress in research on effects of anesthetics and analgesics on Gprotein-coupled receptors. J Anesth2013;27:284-92
105. Minami K, Sudo Y, Shiraishi S, Seo M, Uezono Y: Analysis of the effects of anesthetics andethanol on mu-opioid receptor. J Pharmacol Sci2010;112:424-31
106. Minami K, Sudo Y, Yokoyama T, Ogata J, Takeuchi M, Uezono Y: Sevoflurane inhibits themicro-opioid receptor function expressed in Xenopus oocytes. Pharmacology2011;88:127-32
107. Brown DA, Sihra TS: Presynaptic signaling by heterotrimeric G-proteins. Handb Exp Pharmacol2008:207-60
108. Vulliemoz Y, Verosky M, Triner L: Effect of halothane on myocardial cyclic AMP and cyclic GMPcontent of mice. Journal of Pharmacology and Experimental Therapeutics1986;236:181-186
109. Neubig RR, Siderovski DP: Regulators of G-protein signalling as new central nervous system drugtargets. Nat Rev Drug Discov2002;1:187-97
110. Huang X, Fu Y, Charbeneau RA, Saunders TL, Taylor DK, Hankenson KD, Russell MW, D'AlecyLG, Neubig RR: Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2allele. Mol Cell Biol2006;26:6870-9
111. Sonner JM, Gong D, Li J, Eger EI,2nd, Laster MJ: Mouse strain modestly influences minimumalveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg1999;89:1030-4
112. Sato Y, Kobayashi E, Murayama T, Mishina M, Seo N: Effect of N-methyl-D-aspartate receptorepsilon1subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology2005;102:557-61
113. Petrenko AB, Tsujita M, Kohno T, Sakimura K, Baba H: Mutation of alpha1G T-type calciumchannels in mice does not change anesthetic requirements for loss of the righting reflex and minimumalveolar concentration but delays the onset of anesthetic induction. Anesthesiology2007;106:1177-85
114. Van Dort CJ, Baghdoyan HA, Lydic R: Adenosine A(1) and A(2A) receptors in mouse prefrontalcortex modulate acetylcholine release and behavioral arousal. J Neurosci2009;29:871-81
115. Opp MR: Rat strain differences suggest a role for corticotropin-releasing hormone in modulatingsleep. Physiol Behav1997;63:67-74
116. Bjorness TE, Kelly CL, Gao T, Poffenberger V, Greene RW: Control and function of thehomeostatic sleep response by adenosine A1receptors. J Neurosci2009;29:1267-76
117. Monti JM, Jantos H, Boussard M, Altier H, Orellana C, Olivera S: Effects of selective activation orblockade of the histamine H3receptor on sleep and wakefulness. Eur J Pharmacol1991;205:283-7
118. Linder ME: Gi Family of Heterotrimeric G Proteins, Encyclopedia of Biological Chemistry. Editedby Editors-in-Chief: William JL, Lane MD. New York, Elsevier,2004, pp181-185
119. Shinohara H, Udagawa J, Morishita R, Ueda H, Otani H, Semba R, Kato K, Asano T: Gi2signalingenhances proliferation of neural progenitor cells in the developing brain. J Biol Chem2004;279:41141-8
120. Hollmann MW, Strumper D, Herroeder S, Durieux ME: Receptors, G proteins, and theirinteractions. Anesthesiology2005;103:1066-78
121. Talbot JN, Jutkiewicz EM, Graves SM, Clemans CF, Nicol MR, Mortensen RM, Huang X, NeubigRR, Traynor JR: RGS inhibition at G(alpha)i2selectively potentiates5-HT1A-mediated antidepressanteffects. Proc Natl Acad Sci U S A2010;107:11086-91
122. Ahnaou A, Drinkenburg WH: Disruption of glycogen synthase kinase-3-beta activity leads toabnormalities in physiological measures in mice. Behav Brain Res2011;221:246-52
123. Doi M, Ishida A, Miyake A, Sato M, Komatsu R, Yamazaki F, Kimura I, Tsuchiya S, Kori H, SeoK, Yamaguchi Y, Matsuo M, Fustin JM, Tanaka R, Santo Y, Yamada H, Takahashi Y, Araki M, Nakao K,Aizawa S, Kobayashi M, Obrietan K, Tsujimoto G, Okamura H: Circadian regulation of intracellularG-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus.Nat Commun2011;2:327
124. Takahashi S, Kushikata T, Matsuki A: Effects of isoflurane and ketamine on sleep in rabbits.Psychiatry Clin Neurosci2001;55:239-40
125. Nelson AB, Faraguna U, Tononi G, Cirelli C: Effects of anesthesia on the response to sleepdeprivation. sleep2010;33:1659-67
126. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC: Isoflurane preconditions myocardiumagainst infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology2000;92:1400-1407
127. Hirshman CA, Togashi H, Shao D, Emala CW: Galphai-2is required for carbachol-induced stressfiber formation in human airway smooth muscle cells. Am J Physiol1998;275: L911-6
128. Streiff J, Jones K, Perkins WJ, Warner DO, Jones KA: Effect of halothane on the guanosine5'triphosphate binding activity of G-protein alphai subunits. Anesthesiology2003;99:105-11
129. Ishizawa Y, Sharp R, Liebman PA, Eckenhoff RG: Halothane binding to a G protein coupledreceptor in retinal membranes by photoaffinity labeling. Biochemistry2000;39:8497-502
130. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, Taniyama K, Shigematsu A:Analysis of the effects of halothane on Gi-coupled muscarinic M2receptor signaling in Xenopusoocytes using a chimeric G alpha protein. Pharmacology2004;72:205-12
131. Knill RL, Moote CA, Skinner MI, Rose EA: Anesthesia with abdominal surgery leads to intenseREM sleep during the first postoperative week. Anesthesiology1990;73:52-61
1. McDaniel M, Brudney C: Postoperative delirium: etiology and management. Curr Opin Crit Care2012;18:372-6
2. Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, DonaldsonMC, Whittemore AD, Sugarbaker DJ, Poss R, et al.: A clinical prediction rule for delirium after electivenoncardiac surgery. JAMA1994;271:134-9
3. Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA: Delirium inelderly patients and the risk of postdischarge mortality, institutionalization, and dementia: ameta-analysis. JAMA2010;304:443-51
4. Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN: Cognitivetrajectories after postoperative delirium. N Engl J Med2012;367:30-9
5. Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK: One-year health care costsassociated with delirium in the elderly population. Arch Intern Med2008;168:27-32
6. Fong TG, Tulebaev SR, Inouye SK: Delirium in elderly adults: diagnosis, prevention and treatment.Nat Rev Neurol2009;5:210-20
7. Siddiqi N, House AO, Holmes JD: Occurrence and outcome of delirium in medical in-patients: asystematic literature review. Age Ageing2006;35:350-64
8. Chaput AJ, Bryson GL: Postoperative delirium: risk factors and management: continuingprofessional development. Can J Anaesth2012;59:304-20
9. Skrobik Y: Delirium prevention and treatment. Anesthesiol Clin2011;29:721-7
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ,Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses ofstudies that evaluate healthcare interventions: explanation and elaboration. BMJ2009;339: b2700
11. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. BMJ2009;339
12. Steiner LA: Postoperative delirium. part2: detection, prevention and treatment. Eur J Anaesthesiol2011;28:723-32
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessingthe quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials1996;17:1-12
14. Mangnall LT, Gallagher R, Stein-Parbury J: Postoperative delirium after colorectal surgery in olderpatients. Am J Crit Care2011;20:45-55
15. Whitlock EL, Vannucci A, Avidan MS: Postoperative delirium. Minerva Anestesiol2011;77:448-56
16. Allen SR, Frankel HL: Postoperative complications: delirium. Surg Clin North Am2012;92:409-31, x
17. Berggren D, Gustafson Y, Eriksson B, Bucht G, Hansson LI, Reiz S, Winblad B: Postoperativeconfusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg1987;66:497-504
18. Schindler BA, Shook J, Schwartz GM: Beneficial effects of psychiatric intervention on recoveryafter coronary artery bypass graft surgery. Gen Hosp Psychiatry1989;11:358-64
19. Williams-Russo P, Urquhart BL, Sharrock NE, Charlson ME: Post-operative delirium: predictorsand prognosis in elderly orthopedic patients. J Am Geriatr Soc1992;40:759-67
20. Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME: Cognitive effects afterepidural vs general anesthesia in older adults. A randomized trial. JAMA1995;274:44-50
21. Kim KY, McCartney JR, Kaye W, Boland RJ, Niaura R: The effect of cimetidine and ranitidine oncognitive function in postoperative cardiac surgical patients. Int J Psychiatry Med1996;26:295-307
22. Kaneko T: Prophylactic Consecutive Administration of Haloperidol Can Reduce the Occurrence ofPostoperative Delirium in Gastrointestinal Surgery. Yonago Acta medica1999;42:179-184
23. Williams-Russo P, Sharrock NE, Mattis S, Liguori GA, Mancuso C, Peterson MG, Hollenberg J,Ranawat C, Salvati E, Sculco T: Randomized trial of hypotensive epidural anesthesia in older adults.Anesthesiology1999;91:926-35
24. Mann C, Pouzeratte Y, Boccara G, Peccoux C, Vergne C, Brunat G, Domergue J, Millat B, ColsonP: Comparison of intravenous or epidural patient-controlled analgesia in the elderly after majorabdominal surgery. Anesthesiology2000;92:433-41
25. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM: Reducing delirium after hip fracture: arandomized trial. J Am Geriatr Soc2001;49:516-22
26. Aizawa K, Kanai T, Saikawa Y, Takabayashi T, Kawano Y, Miyazawa N, Yamamoto T: A novelapproach to the prevention of postoperative delirium in the elderly after gastrointestinal surgery. SurgToday2002;32:310-4
27. Kudoh A, Takase H, Takazawa T: A comparison of anesthetic quality in propofol-spinal anesthesiaand propofol-fentanyl anesthesia for total knee arthroplasty in elderly patients. J Clin Anesth2004;16:405-10
28. Nishikawa K, Nakayama M, Omote K, Namiki A: Recovery characteristics and post-operativedelirium after long-duration laparoscope-assisted surgery in elderly patients: propofol-based vs.sevoflurane-based anesthesia. Acta Anaesthesiol Scand2004;48:162-8
29. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P,van Gool WA: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: arandomized placebo-controlled study. J Am Geriatr Soc2005;53:1658-66
30. Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R: Donepezil in the prevention and treatment ofpost-surgical delirium. Am J Geriatr Psychiatry2005;13:1100-6
31. Papaioannou A, Fraidakis O, Michaloudis D, Balalis C, Askitopoulou H: The impact of the type ofanaesthesia on cognitive status and delirium during the first postoperative days in elderly patients. Eur JAnaesthesiol2005;22:492-9
32. Beaussier M, Weickmans H, Parc Y, Delpierre E, Camus Y, Funck-Brentano C, Schiffer E, Delva E,Lienhart A: Postoperative analgesia and recovery course after major colorectal surgery in elderlypatients: a randomized comparison between intrathecal morphine and intravenous PCA morphine. RegAnesth Pain Med2006;31:531-8
33. Leung JM, Sands LP, Rico M, Petersen KL, Rowbotham MC, Dahl JB, Ames C, Chou D,Weinstein P: Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.Neurology2006;67:1251-3
34. Leung JM, Sands LP, Vaurio LE, Wang Y: Nitrous oxide does not change the incidence ofpostoperative delirium or cognitive decline in elderly surgical patients. Br J Anaesth2006;96:754-60
35. Lundstrom M, Olofsson B, Stenvall M, Karlsson S, Nyberg L, Englund U, Borssen B, Svensson O,Gustafson Y: Postoperative delirium in old patients with femoral neck fracture: a randomizedintervention study. Aging Clin Exp Res2007;19:178-86
36. Prakanrattana U, Prapaitrakool S: Efficacy of risperidone for prevention of postoperative deliriumin cardiac surgery. Anaesth Intensive Care2007;35:714-9
37. Sampson EL, Raven PR, Ndhlovu PN, Vallance A, Garlick N, Watts J, Blanchard MR, Bruce A,Blizard R, Ritchie CW: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride(Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int JGeriatr Psychiatry2007;22:343-9
38. Taguchi T, Yano M, Kido Y: Influence of bright light therapy on postoperative patients: a pilotstudy. Intensive Crit Care Nurs2007;23:289-97
39. Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, Filipovic M,Seeberger MD, Pargger H, Siegemund M, Carrel T, Seiler WO, Berres M, Strebel SP, Monsch AU,Steiner LA: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoingelective cardiac surgery--a randomized controlled trial. Crit Care Med2009;37:1762-8
40. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Byrne AJ, Hudetz AG, Warltier DC, Pagel PS:Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac VascAnesth2009;23:651-7
41. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA: Dexmedetomidine andthe reduction of postoperative delirium after cardiac surgery. Psychosomatics2009;50:206-17
42. McCaffrey R: The effect of music on acute confusion in older adults after hip or knee surgery. ApplNurs Res2009;22:107-12
43. Mouzopoulos G, Vasiliadis G, Lasanianos N, Nikolaras G, Morakis E, Kaminaris M: Fascia iliacablock prophylaxis for hip fracture patients at risk for delirium: a randomized placebo-controlled study. JOrthop Traumatol2009;10:127-33
44. Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J: Prevalence ofdelirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: arandomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).Anesthesiology2009;111:1075-84
45. Larsen KA, Kelly SE, Stern TA, Bode RH, Jr., Price LL, Hunter DJ, Gulczynski D, Bierbaum BE,Sweeney GA, Hoikala KA, Cotter JJ, Potter AW: Administration of olanzapine to prevent postoperativedelirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics2010;51:409-18
46. Rubino AS, Onorati F, Caroleo S, Galato E, Nucera S, Amantea B, Santini F, Renzulli A: Impact ofclonidine administration on delirium and related respiratory weaning after surgical correction of acutetype-A aortic dissection: results of a pilot study. Interact Cardiovasc Thorac Surg2010;10:58-62
47. Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, Mears SC: Sedationdepth during spinal anesthesia and the development of postoperative delirium in elderly patientsundergoing hip fracture repair. Mayo Clin Proc2010;85:18-26
48. Marcantonio ER, Palihnich K, Appleton P, Davis RB: Pilot randomized trial of donepezilhydrochloride for delirium after hip fracture. J Am Geriatr Soc2011;59Suppl2: S282-8
49. Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y: The usefulness of bright light therapy for patientsafter oesophagectomy. Intensive Crit Care Nurs2011;27:158-66
50. Pesonen A, Suojaranta-Ylinen R, Hammaren E, Kontinen VK, Raivio P, Tarkkila P, Rosenberg PH:Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomizedplacebo-controlled trial. Br J Anaesth2011;106:873-81
51. Royse CF, Andrews DT, Newman SN, Stygall J, Williams Z, Pang J, Royse AG: The influence ofpropofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary arterybypass surgery. Anaesthesia2011;66:455-64
52. Hakim SM, Othman AI, Naoum DO: Early Treatment with Risperidone for SubsyndromalDelirium after On-pump Cardiac Surgery in the Elderly: A Randomized Trial. Anesthesiology2012;116:987-97
53. Musclow SL, Bowers T, Vo H, Glube M, Nguyen T: Long-acting morphine following hip or kneereplacement: a randomized, double-blind and placebo-controlled trial. Pain Res Manag2012;17:83-8
54. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN: Haloperidolprophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomizedcontrolled trial*. Crit Care Med2012;40:731-9
55. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME: A predictive model for delirium inhospitalized elderly medical patients based on admission characteristics. Ann Intern Med1993;119:474-81
56. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons.Predictive model and interrelationship with baseline vulnerability. JAMA1996;275:852-7
57. Wells GA, Sultan SA, Chen L, Khan M, D C: Indirect treatment comparison [computer program].Version2.0. Ottawa: Canadian Agency for Drugs and Technologies in Health Available from:http://cadth.ca/en/resources/about-this-guide/download-software2009
58. Lin YY, He B, Chen J, Wang ZN: Can dexmedetomidine be a safe and efficacious sedative agent inpost-cardiac surgery patients? a meta-analysis. Crit Care2012;16: R169
59. Lin Y, Chen J, Wang Z: Meta-analysis of factors which influence delirium following cardiacsurgery. J Card Surg2012;27:481-92
60. Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adultpatients: a meta-analysis. Intensive Care Med2010;36:926-39
61. Devlin JW, Skrobik Y: Antipsychotics for the Prevention and Treatment of Delirium in theIntensive Care Unit: What Is Their Role? Harvard Review of Psychiatry2011;19:59-67
62. Lonergan E, Britton AM, Luxenberg J, Wyller T: Antipsychotics for delirium. Cochrane DatabaseSyst Rev2007: CD005594
63. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E: Efficacyand safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized,double-blind, placebo-controlled pilot study. Crit Care Med2010;38:419-27
64. Devlin J, Skrobik Y, Riker R, Hinderleider E, Roberts R, Fong J, Ruthazer R, Hill N, Garpestad E:Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients withdelirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Crit Care2011;15: R215
65. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium ina critical care setting. Intensive Care Med2004;30:444-9
66. Campbell N, Boustani MA, Ayub A, Fox GC, Munger SL, Ott C, Guzman O, Farber M,Ademuyiwa A, Singh R: Pharmacological management of delirium in hospitalized adults--a systematicevidence review. J Gen Intern Med2009;24:848-53
67. Devlin JW, Al-Qadhee NS, Skrobik Y: Pharmacologic prevention and treatment of delirium incritically ill and non-critically ill hospitalised patients: a review of data from prospective, randomisedstudies. Best Pract Res Clin Anaesthesiol2012;26:289-309
68. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S,Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatmentof delirium in hospitalized AIDS patients. Am J Psychiatry1996;153:231-7
69. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium.Psychosomatics2004;45:297-301
70. Grover S, Kumar V, Chakrabarti S: Comparative efficacy study of haloperidol, olanzapine andrisperidone in delirium. J Psychosom Res2011;71:277-81
71. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT,Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, Investigators MT: Feasibility,efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized,placebo-controlled trial. Crit Care Med2010;38:428-37
72. O'Mahony R, Murthy L, Akunne A, Young J, Guideline Development G: Synopsis of the NationalInstitute for Health and Clinical Excellence guideline for prevention of delirium. Ann Intern Med2011;154:746-51
73. Popp J, Arlt S: Prevention and treatment options for postoperative delirium in the elderly. CurrOpin Psychiatry2012;25:515-21
74. Deschodt M, Braes T, Flamaing J, Detroyer E, Broos P, Haentjens P, Boonen S, Milisen K:Preventing delirium in older adults with recent hip fracture through multidisciplinary geriatricconsultation. J Am Geriatr Soc2012;60:733-9
75. Mouchoux C, Rippert P, Duclos A, Fassier T, Bonnefoy M, Comte B, Heitz D, Colin C,Krolak-Salmon P: Impact of a multifaceted program to prevent postoperative delirium in the elderly: theCONFUCIUS stepped wedge protocol. BMC Geriatr2011;11:25
76. Saltvedt I, Prestmo A, Einarsen E, Johnsen LG, Helbostad JL, Sletvold O: Development anddelivery of patient treatment in the Trondheim Hip Fracture Trial. A new geriatric in-hospital pathwayfor elderly patients with hip fracture. BMC Res Notes2012;5:355
77. Wyller TB, Watne LO, Torbergsen A, Engedal K, Frihagen F, Juliebo V, Saltvedt I, Skovlund E,Raeder J, Conroy S: The effect of a pre-and post-operative orthogeriatric service on cognitive functionin patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial. BMC Geriatr2012;12:36
78. Edelstein DM, Aharonoff GB, Karp A, Capla EL, Zuckerman JD, Koval KJ: Effect ofpostoperative delirium on outcome after hip fracture. Clin Orthop Relat Res2004:195-200
79. Gonzalez M, Martinez G, Calderon J, Villarroel L, Yuri F, Rojas C, Jeria A, Valdivia G, Marin PP,Carrasco M: Impact of delirium on short-term mortality in elderly inpatients: a prospective cohort study.Psychosomatics2009;50:234-8
80. Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M: Postoperative delirium inthe elderly: risk factors and outcomes. Ann Surg2009;249:173-8
81. Boustani MA, Campbell NL, Khan BA, Abernathy G, Zawahiri M, Campbell T, Tricker J, Hui SL,Buckley JD, Perkins AJ, Farber MO, Callahan CM: Enhancing care for hospitalized older adults withcognitive impairment: a randomized controlled trial. J Gen Intern Med2012;27:561-7
82. Stenvall M, Berggren M, Lundstrom M, Gustafson Y, Olofsson B: A multidisciplinary interventionprogram improved the outcome after hip fracture for people with dementia--subgroup analyses of arandomized controlled trial. Arch Gerontol Geriatr2012;54: e284-9
83. Holtta E, Laakkonen ML, Laurila JV, Strandberg TE, Tilvis R, Kautiainen H, Pitkala KH: Theoverlap of delirium with neuropsychiatric symptoms among patients with dementia. Am J GeriatrPsychiatry2011;19:1034-41
84. Landreville P, Voyer P, Carmichael PH: Relationship between delirium and behavioral symptomsof dementia. Int Psychogeriatr2013;25:635-43
85. Silverstein JH, Deiner SG: Perioperative delirium and its relationship to dementia. ProgNeuropsychopharmacol Biol Psychiatry2012;43C:108-115
86. Steiner LA: Postoperative delirium. Part1: pathophysiology and risk factors. Eur J Anaesthesiol2011;28:628-36
87. Robinson TN, Raeburn CD, Tran ZV, Brenner LA, Moss M: Motor subtypes of postoperativedelirium in older adults. Arch Surg2011;146:295-300
2. Veselis RA: Memory: a guide for anaesthetists. Best Pract Res Clin Anaesthesiol2007;21:297-312
3. Veselis RA, Pryor KO, Reinsel RA, Mehta M, Pan H, Johnson R, Jr.: Low-dose propofol-inducedamnesia is not due to a failure of encoding: left inferior prefrontal cortex is still active. Anesthesiology2008;109:213-24
4. Deeprose C, Andrade J, Varma S, Edwards N: Unconscious learning during surgery with propofolanaesthesia. Br J Anaesth2004;92:171-7
5. Beracochea D: Anterograde and retrograde effects of benzodiazepines on memory.ScientificWorldJournal2006;6:1460-5
6. Wang DS, Orser BA: Inhibition of learning and memory by general anesthetics. Can J Anaesth2011;58:167-77
7. Pryor KO, Reinsel RA, Mehta M, Li Y, Wixted JT, Veselis RA: Visual P2-N2complex and arousalat the time of encoding predict the time domain characteristics of amnesia for multiple intravenousanesthetic drugs in humans. Anesthesiology2010;113:313-26
8. Veselis RA, Reinsel RA, Feshchenko VA, Johnson R, Jr.: Information loss over time defines thememory defect of propofol: a comparative response with thiopental and dexmedetomidine.Anesthesiology2004;101:831-41
9. Veselis RA, Pryor KO, Reinsel RA, Li Y, Mehta M, Johnson R, Jr.: Propofol and midazolam inhibitconscious memory processes very soon after encoding: an event-related potential study of familiarityand recollection in volunteers. Anesthesiology2009;110:295-312
10. Alkire MT, Vazdarjanova A, Dickinson-Anson H, White NS, Cahill L: Lesions of the basolateralamygdala complex block propofol-induced amnesia for inhibitory avoidance learning in rats.Anesthesiology2001;95:708-15
11. Ren Y, Zhang FJ, Xue QS, Zhao X, Yu BW: Bilateral inhibition of gamma-aminobutyric acid typeA receptor function within the basolateral amygdala blocked propofol-induced amnesia andactivity-regulated cytoskeletal protein expression inhibition in the hippocampus. Anesthesiology2008;109:775-81
12. D'Hooge R, De Deyn PP: Applications of the Morris water maze in the study of learning andmemory. Brain Res Brain Res Rev2001;36:60-90
13. Crystal JD: Episodic-like memory in animals. Behav Brain Res2010;215:235-43
14. Vorhees CV, Williams MT: Morris water maze: procedures for assessing spatial and related formsof learning and memory. Nat Protoc2006;1:848-58
15. Neves G, Cooke SF, Bliss TV: Synaptic plasticity, memory and the hippocampus: a neural networkapproach to causality. Nat Rev Neurosci2008;9:65-75
16. Alkire MT, Guzowski JF: Hypothesis: suppression of memory protein formation underliesanesthetic-induced amnesia. Anesthesiology2008;109:768-70
17. Gold PE: The many faces of amnesia. Learn Mem2006;13:506-14
18. Alberini CM: Transcription factors in long-term memory and synaptic plasticity. Physiol Rev2009;89:121-45
19. Barco A, Marie H: Genetic approaches to investigate the role of CREB in neuronal plasticity andmemory. Mol Neurobiol2011;44:330-49
20. Florian C, Mons N, Roullet P: CREB antisense oligodeoxynucleotide administration into the dorsalhippocampal CA3region impairs long-but not short-term spatial memory in mice. Learn Mem2006;13:465-72
21. Nguyen PV: CREB and the enhancement of long-term memory. Trends Neurosci2001;24:314
22. Kandel ER: The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB.Mol Brain2012;5:14
23. Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura M, Takemoto-KimuraS, Worley PF, Bito H: Synaptic activity-responsive element in the Arc/Arg3.1promoter essential forsynapse-to-nucleus signaling in activated neurons. Proc Natl Acad Sci U S A2009;106:316-21
24. Fibuch EE, Wang JQ: Inhibition of the MAPK/ERK cascade: a potential transcription-dependentmechanism for the amnesic effect of anesthetic propofol. Neurosci Bull2007;23:119-24
25. Kozinn J, Mao L, Arora A, Yang L, Fibuch EE, Wang JQ: Inhibition of glutamatergic activation ofextracellular signal-regulated protein kinases in hippocampal neurons by the intravenous anestheticpropofol. Anesthesiology2006;105:1182-91
26. Kidambi S, Yarmush J, Berdichevsky Y, Kamath S, Fong W, Schianodicola J: Propofol inducesMAPK/ERK cascade dependant expression of cFos and Egr-1in rat hippocampal slices. BMC ResNotes2010;3:201
27. Cui X, Li J, Li T, Ji F, Bu X, Zhang N, Zhang B: Propofol and ketamine-induced anestheticdepth-dependent decrease of CaMKII phosphorylation levels in rat hippocampus and cortex. JNeurosurg Anesthesiol2009;21:145-54
28. Vutskits L, Lysakowski C, Czarnetzki C, Jenny B, Copin JC, Tramer MR: Plasma concentrationsof brain-derived neurotrophic factor in patients undergoing minor surgery: a randomized controlled trial.Neurochem Res2008;33:1325-31
29. Vecsey CG, Baillie GS, Jaganath D, Havekes R, Daniels A, Wimmer M, Huang T, Brown KM, LiXY, Descalzi G, Kim SS, Chen T, Shang YZ, Zhuo M, Houslay MD, Abel T: Sleep deprivation impairscAMP signalling in the hippocampus. Nature2009;461:1122-5
30. Barad M, Bourtchouladze R, Winder DG, Golan H, Kandel E: Rolipram, a type IV-specificphosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation andimproves memory. Proc Natl Acad Sci U S A1998;95:15020-5
31. Zhang HT, O'Donnell JM: Phosphodiesterase-4as a pharmacological target mediatingantidepressant and cognitive effects on behavior, Phosphodiesterases in Health and Disease. London,UK, CRC Press,2007, pp539-558
32. Giorgi M, Modica A, Pompili A, Pacitti C, Gasbarri A: The induction of cyclic nucleotidephosphodiesterase4gene (PDE4D) impairs memory in a water maze task. Behav Brain Res2004;154:99-106
33. Krause W, Kuhne G: Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the ratand the rabbit. Studies on species differences. Xenobiotica1988;18:561-71
34. Laalou FZ, de Vasconcelos AP, Oberling P, Jeltsch H, Cassel JC, Pain L: Involvement of the basalcholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology2008;108:888-96
35. Gamou S, Fukuda S, Ogura M, Sakamoto H, Morita S: Microinjection of propofol into theperifornical area induces sedation with decreasing cortical acetylcholine release in rats. Anesth Analg2010;111:395-402
36. Feldman LA, Shapiro ML, Nalbantoglu J: A novel, rapidly acquired and persistent spatial memorytask that induces immediate early gene expression. Behav Brain Funct2010;6:35
37. Ward CP, McCarley RW, Strecker RE: Experimental sleep fragmentation impairs spatial referencebut not working memory in Fischer/Brown Norway rats. J Sleep Res2009;18:238-44
38. Quan HX, Jin JY, Wen JF, Cho KW:[beta]1-Adrenergic receptor activation decreases ANP releasevia cAMP-Ca2+signaling in perfused beating rabbit atria. Life Sciences2010;87:246-253
39. Zu L, He J, Jiang H, Xu C, Pu S, Xu G: Bacterial endotoxin stimulates adipose lipolysis viatoll-like receptor4and extracellular signal-regulated kinase pathway. J Biol Chem2009;284:5915-26
40. Stanley JL, Lincoln RJ, Brown TA, McDonald LM, Dawson GR, Reynolds DS: The mouse beamwalking assay offers improved sensitivity over the mouse rotarod in determining motor coordinationdeficits induced by benzodiazepines. J Psychopharmacol2005;19:221-7
41. Engeland CG, Vanderwolf CH, Gelb AW: Rats show unimpaired learning within minutes afterrecovery from single bolus propofol anesthesia. Can J Anaesth1999;46:586-92
42. Scoville WB, Milner B: Loss of recent memory after bilateral hippocampal lesions. J NeurolNeurosurg Psychiatry1957;20:11-21
43. Wei H, Xiong W, Yang S, Zhou Q, Liang C, Zeng BX, Xu L: Propofol facilitates the developmentof long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1region of the hippocampus of anesthetized rats. Neurosci Lett2002;324:181-4
44. Wang W, Wang H, Gong N, Xu TL: Changes of K+-Cl-cotransporter2(KCC2) and circuitactivity in propofol-induced impairment of long-term potentiation in rat hippocampal slices. Brain ResBull2006;70:444-9
45. Zhang M, Storm DR, Wang H: Bidirectional synaptic plasticity and spatial memory flexibilityrequire Ca2+-stimulated adenylyl cyclases. J Neurosci2011;31:10174-83
46. Kurokawa H, Murray PA, Damron DS: Propofol attenuates beta-adrenoreceptor-mediated signaltransduction via a protein kinase C-dependent pathway in cardiomyocytes. Anesthesiology2002;96:688-98
47. Wang Y, Kikuchi T, Sakai M, Wu JL, Sato K, Okumura F: Age-related modifications of effects ofketamine and propofol on rat hippocampal acetylcholine release studied by in vivo brain microdialysis.Acta Anaesthesiol Scand2000;44:112-7
48. Bernabeu R, Bevilaqua L, Ardenghi P, Bromberg E, Schmitz P, Bianchin M, Izquierdo I, MedinaJH: Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a latememory consolidation phase of aversively motivated learning in rats. Proc Natl Acad Sci U S A1997;94:7041-6
49. Kida S, Josselyn SA, Pena de Ortiz S, Kogan JH, Chevere I, Masushige S, Silva AJ: CREBrequired for the stability of new and reactivated fear memories. Nat Neurosci2002;5:348-55
50. Lu Y, Christian K, Lu B: BDNF: a key regulator for protein synthesis-dependent LTP andlong-term memory? Neurobiol Learn Mem2008;89:312-23
51. Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H: The experimental and clinicalpharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther2008;14:95-106
52. Lawton BK, Brown NJ, Reilly CS, Brookes ZL: Role of L-type calcium channels in alteredmicrovascular responses to propofol in hypertension. Br J Anaesth2012;108:929-35
53. Linnarsson S, Bjorklund A, Ernfors P: Learning deficit in BDNF mutant mice. Eur J Neurosci1997;9:2581-7
54. Montkowski A, Holsboer F: Intact spatial learning and memory in transgenic mice with reducedBDNF. Neuroreport1997;8:779-82
55. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ: Hippocampus-specific deletion of BDNF in adultmice impairs spatial memory and extinction of aversive memories. Mol Psychiatry2007;12:656-70
56. Korb E, Finkbeiner S: Arc in synaptic plasticity: from gene to behavior. Trends Neurosci2011;34:591-8
57. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA:Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenanceof long-term potentiation and the consolidation of long-term memory. J Neurosci2000;20:3993-4001
58. Monti B, Berteotti C, Contestabile A: Subchronic rolipram delivery activates hippocampal CREBand arc, enhances retention and slows down extinction of conditioned fear. Neuropsychopharmacology2006;31:278-86
59. Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O: Persistent improvement insynaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest2004;114:1624-34
60. Yu X, Guo L, Yin G, Zong X, Ai Y: Effect of non-specific HCN1blocker CsCl on spatial learningand memory in mouse. J Huazhong Univ Sci Technolog Med Sci2006;26:164-6
61. Grandoch M, Roscioni SS, Schmidt M: The role of Epac proteins, novel cAMP mediators, in theregulation of immune, lung and neuronal function. Br J Pharmacol2010;159:265-84
62. Perez-Torres S, Miro X, Palacios JM, Cortes R, Puigdomenech P, Mengod G: Phosphodiesterasetype4isozymes expression in human brain examined by in situ hybridization histochemistryand[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanat2000;20:349-74
63. Ahmed T, Frey JU: Expression of the specific type IV phosphodiesterase gene PDE4B3duringdifferent phases of long-term potentiation in single hippocampal slices of rats in vitro. Neuroscience2003;117:627-38
64. Sanou J, Ilboudo D, Goodall G, Bourdalle-Badie C, Erny P:[Evaluation of cognitive functionsafter anesthesia with propofol]. Ann Fr Anesth Reanim1996;15:1155-61
65. Padmanabhan U, Leslie K, Eer AS, Maruff P, Silbert BS: Early cognitive impairment after sedationfor colonoscopy: the effect of adding midazolam and/or fentanyl to propofol. Anesth Analg2009;109:1448-55
66. Collado MC, Beleta J, Martinez E, Miralpeix M, Domenech T, Palacios JM, Hernandez J:Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type4inhibitor. Br J Pharmacol1998;123:1047-54
67. Lydic R, Baghdoyan HA: Sleep, anesthesiology, and the neurobiology of arousal state control.Anesthesiology2005;103:1268-95
68. Mashour GA, Pal D: Interfaces of sleep and anesthesia. Anesthesiol Clin2012;30:385-98
69. Shadan S: Neuroscience: Sleep to oblivion. Nature2012;491:46
70. Moore JT, Chen J, Han B, Meng QC, Veasey SC, Beck SG, Kelz MB: Direct activation ofsleep-promoting VLPO neurons by volatile anesthetics contributes to anesthetic hypnosis. Curr Biol2012;22:2008-16
71. Brown EN, Lydic R, Schiff ND: General anesthesia, sleep, and coma. N Engl J Med2010;363:2638-50
72. Muller CP, Pum ME, Amato D, Schuttler J, Huston JP, Silva MA: The in vivo neurochemistry ofthe brain during general anesthesia. J Neurochem2011;119:419-46
73. Watson CJ, Baghdoyan HA, Lydic R: Neuropharmacology of Sleep and Wakefulness. Sleep MedClin2010;5:513-528
74. Cirelli C, Bushey D, Hill S, Huber R, Kreber R, Ganetzky B, Tononi G: Reduced sleep inDrosophila Shaker mutants. Nature2005;434:1087-92
75. Weber B, Schaper C, Bushey D, Rohlfs M, Steinfath M, Tononi G, Cirelli C, Scholz J, Bein B:Increased volatile anesthetic requirement in short-sleeping Drosophila mutants. Anesthesiology2009;110:313-6
76. Ouyang M, Hellman K, Abel T, Thomas SA: Adrenergic signaling plays a critical role in themaintenance of waking and in the regulation of REM sleep. J Neurophysiol2004;92:2071-82
77. Hu FY, Hanna GM, Han W, Mardini F, Thomas SA, Wyner AJ, Kelz MB: Hypnotichypersensitivity to volatile anesthetics and dexmedetomidine in dopamine beta-hydroxylase knockoutMice. Anesthesiology2012;117:1006-17
78. Icaza EE, Huang X, Fu Y, Neubig RR, Baghdoyan HA, Lydic R: Isoflurane-induced changes inrighting response and breathing are modulated by RGS proteins. Anesth Analg2009;109:1500-5
79. Kain ZN, Mayes LC, Caldwell-Andrews AA, Alexander GM, Krivutza D, Teague BA, Wang SM:Sleeping characteristics of children undergoing outpatient elective surgery. Anesthesiology2002;97:1093-101
80. G genur I, Rosenberg J: Sleep Disturbances after Noncardiac Surgery, Sleep: A ComprehensiveHandbook, John Wiley&Sons, Inc.,2005, pp913-925
81. Gogenur I, Wildschiotz G, Rosenberg J: Circadian distribution of sleep phases after majorabdominal surgery. Br J Anaesth2008;100:45-9
82. Krenk L, Jennum P, Kehlet H: Sleep disturbances after fast-track hip and knee arthroplasty. Br JAnaesth2012;109:769-75
83. Dette F, Cassel W, Urban F, Zoremba M, Koehler U, Wulf H, Graf J, Steinfeldt T: Occurrence ofrapid eye movement sleep deprivation after surgery under regional anesthesia. Anesth Analg2013;116:939-43
84. White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV: Sleep deprivation and the control ofventilation. Am Rev Respir Dis1983;128:984-6
85. Knill RL, Skinner MI, Novick T, Vandenberghe HM, Moote CA: The night of intense REM sleepafter anesthesia and surgery increases urinary catecholamines. Can J Anaesth1990;37: S12
86. Rosenberg J, Rasmussen V, von Jessen F, Ullstad T, Kehlet H: Late postoperative episodic andconstant hypoxaemia and associated ECG abnormalities. Br J Anaesth1990;65:684-91
87. Rosenberg J, Wildschiodtz G, Pedersen MH, von Jessen F, Kehlet H: Late postoperative nocturnalepisodic hypoxaemia and associated sleep pattern. Br J Anaesth1994;72:145-50
88. Rosenberg-Adamsen S, Kehlet H, Dodds C, Rosenberg J: Postoperative sleep disturbances:mechanisms and clinical implications. Br J Anaesth1996;76:552-9
89. Kotiniemi LH, Ryhanen PT, Moilanen IK: Behavioural changes in children following day-casesurgery: a4-week follow-up of551children. Anaesthesia1997;52:970-6
90. Kushikata T, Yoshida H, Hirota K: Sleep in anesthesiology–What can we learn about anesthesiafrom studying sleep? Trends in Anaesthesia and Critical Care2012;2:30-35
91. Vasu TS, Grewal R, Doghramji K: Obstructive sleep apnea syndrome and perioperativecomplications: a systematic review of the literature. J Clin Sleep Med2012;8:199-207
92. Venkateshiah SB, Collop NA: Sleep and sleep disorders in the hospital. Chest2012;141:1337-45
93. Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y: The usefulness of bright light therapy for patientsafter oesophagectomy. Intensive Crit Care Nurs2011;27:158-66
94. Taguchi T, Yano M, Kido Y: Influence of bright light therapy on postoperative patients: a pilotstudy. Intensive Crit Care Nurs2007;23:289-97
95. Moote CA, Knill RL: Isoflurane anesthesia causes a transient alteration in nocturnal sleep.Anesthesiology1988;69:327-31
96. Steinmetz J, Holm-Knudsen R, Eriksen K, Marxen D, Rasmussen LS: Quality differences inpostoperative sleep between propofol-remifentanil and sevoflurane anesthesia in infants. Anesth Analg2007;104:779-83
97. Tung A, Lynch JP, Mendelson WB: Prolonged sedation with propofol in the rat does not result insleep deprivation. Anesth Analg2001;92:1232-6
98. Mashour GA, Lipinski WJ, Matlen LB, Walker AJ, Turner AM, Schoen W, Lee U, Poe GR:Isoflurane anesthesia does not satisfy the homeostatic need for rapid eye movement sleep. Anesth Analg2010;110:1283-9
99. Pick J, Chen Y, Moore JT, Sun Y, Wyner AJ, Friedman EB, Kelz MB: Rapid eye movement sleepdebt accrues in mice exposed to volatile anesthetics. Anesthesiology2011;115:702-12
100. Tung A, Bergmann BM, Herrera S, Cao D, Mendelson WB: Recovery from sleep deprivationoccurs during propofol anesthesia. Anesthesiology2004;100:1419-26
101. Pal D, Lipinski WJ, Walker AJ, Turner AM, Mashour GA: State-specific effects of sevofluraneanesthesia on sleep homeostasis: selective recovery of slow wave but not rapid eye movement sleep.Anesthesiology2011;114:302-10
102. Jang HS, Jung JY, Jang KH, Lee MG: Effects of isoflurane anesthesia on post-anestheticsleep-wake architectures in rats. Korean J Physiol Pharmacol2010;14:291-7
103. Styer AM, Mirshahi UL, Wang C, Girard L, Jin T, Logothetis DE, Mirshahi T: G Protein βγ GatingConfers Volatile Anesthetic Inhibition to Kir3Channels. Journal of Biological Chemistry2010;285:41290-41299
104. Minami K, Uezono Y: The recent progress in research on effects of anesthetics and analgesics on Gprotein-coupled receptors. J Anesth2013;27:284-92
105. Minami K, Sudo Y, Shiraishi S, Seo M, Uezono Y: Analysis of the effects of anesthetics andethanol on mu-opioid receptor. J Pharmacol Sci2010;112:424-31
106. Minami K, Sudo Y, Yokoyama T, Ogata J, Takeuchi M, Uezono Y: Sevoflurane inhibits themicro-opioid receptor function expressed in Xenopus oocytes. Pharmacology2011;88:127-32
107. Brown DA, Sihra TS: Presynaptic signaling by heterotrimeric G-proteins. Handb Exp Pharmacol2008:207-60
108. Vulliemoz Y, Verosky M, Triner L: Effect of halothane on myocardial cyclic AMP and cyclic GMPcontent of mice. Journal of Pharmacology and Experimental Therapeutics1986;236:181-186
109. Neubig RR, Siderovski DP: Regulators of G-protein signalling as new central nervous system drugtargets. Nat Rev Drug Discov2002;1:187-97
110. Huang X, Fu Y, Charbeneau RA, Saunders TL, Taylor DK, Hankenson KD, Russell MW, D'AlecyLG, Neubig RR: Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2allele. Mol Cell Biol2006;26:6870-9
111. Sonner JM, Gong D, Li J, Eger EI,2nd, Laster MJ: Mouse strain modestly influences minimumalveolar anesthetic concentration and convulsivity of inhaled compounds. Anesth Analg1999;89:1030-4
112. Sato Y, Kobayashi E, Murayama T, Mishina M, Seo N: Effect of N-methyl-D-aspartate receptorepsilon1subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology2005;102:557-61
113. Petrenko AB, Tsujita M, Kohno T, Sakimura K, Baba H: Mutation of alpha1G T-type calciumchannels in mice does not change anesthetic requirements for loss of the righting reflex and minimumalveolar concentration but delays the onset of anesthetic induction. Anesthesiology2007;106:1177-85
114. Van Dort CJ, Baghdoyan HA, Lydic R: Adenosine A(1) and A(2A) receptors in mouse prefrontalcortex modulate acetylcholine release and behavioral arousal. J Neurosci2009;29:871-81
115. Opp MR: Rat strain differences suggest a role for corticotropin-releasing hormone in modulatingsleep. Physiol Behav1997;63:67-74
116. Bjorness TE, Kelly CL, Gao T, Poffenberger V, Greene RW: Control and function of thehomeostatic sleep response by adenosine A1receptors. J Neurosci2009;29:1267-76
117. Monti JM, Jantos H, Boussard M, Altier H, Orellana C, Olivera S: Effects of selective activation orblockade of the histamine H3receptor on sleep and wakefulness. Eur J Pharmacol1991;205:283-7
118. Linder ME: Gi Family of Heterotrimeric G Proteins, Encyclopedia of Biological Chemistry. Editedby Editors-in-Chief: William JL, Lane MD. New York, Elsevier,2004, pp181-185
119. Shinohara H, Udagawa J, Morishita R, Ueda H, Otani H, Semba R, Kato K, Asano T: Gi2signalingenhances proliferation of neural progenitor cells in the developing brain. J Biol Chem2004;279:41141-8
120. Hollmann MW, Strumper D, Herroeder S, Durieux ME: Receptors, G proteins, and theirinteractions. Anesthesiology2005;103:1066-78
121. Talbot JN, Jutkiewicz EM, Graves SM, Clemans CF, Nicol MR, Mortensen RM, Huang X, NeubigRR, Traynor JR: RGS inhibition at G(alpha)i2selectively potentiates5-HT1A-mediated antidepressanteffects. Proc Natl Acad Sci U S A2010;107:11086-91
122. Ahnaou A, Drinkenburg WH: Disruption of glycogen synthase kinase-3-beta activity leads toabnormalities in physiological measures in mice. Behav Brain Res2011;221:246-52
123. Doi M, Ishida A, Miyake A, Sato M, Komatsu R, Yamazaki F, Kimura I, Tsuchiya S, Kori H, SeoK, Yamaguchi Y, Matsuo M, Fustin JM, Tanaka R, Santo Y, Yamada H, Takahashi Y, Araki M, Nakao K,Aizawa S, Kobayashi M, Obrietan K, Tsujimoto G, Okamura H: Circadian regulation of intracellularG-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus.Nat Commun2011;2:327
124. Takahashi S, Kushikata T, Matsuki A: Effects of isoflurane and ketamine on sleep in rabbits.Psychiatry Clin Neurosci2001;55:239-40
125. Nelson AB, Faraguna U, Tononi G, Cirelli C: Effects of anesthesia on the response to sleepdeprivation. sleep2010;33:1659-67
126. Toller WG, Kersten JR, Gross ER, Pagel PS, Warltier DC: Isoflurane preconditions myocardiumagainst infarction via activation of inhibitory guanine nucleotide binding proteins. Anesthesiology2000;92:1400-1407
127. Hirshman CA, Togashi H, Shao D, Emala CW: Galphai-2is required for carbachol-induced stressfiber formation in human airway smooth muscle cells. Am J Physiol1998;275: L911-6
128. Streiff J, Jones K, Perkins WJ, Warner DO, Jones KA: Effect of halothane on the guanosine5'triphosphate binding activity of G-protein alphai subunits. Anesthesiology2003;99:105-11
129. Ishizawa Y, Sharp R, Liebman PA, Eckenhoff RG: Halothane binding to a G protein coupledreceptor in retinal membranes by photoaffinity labeling. Biochemistry2000;39:8497-502
130. Minami K, Uezono Y, Shiraishi M, Okamoto T, Ogata J, Horishita T, Taniyama K, Shigematsu A:Analysis of the effects of halothane on Gi-coupled muscarinic M2receptor signaling in Xenopusoocytes using a chimeric G alpha protein. Pharmacology2004;72:205-12
131. Knill RL, Moote CA, Skinner MI, Rose EA: Anesthesia with abdominal surgery leads to intenseREM sleep during the first postoperative week. Anesthesiology1990;73:52-61
1. McDaniel M, Brudney C: Postoperative delirium: etiology and management. Curr Opin Crit Care2012;18:372-6
2. Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, DonaldsonMC, Whittemore AD, Sugarbaker DJ, Poss R, et al.: A clinical prediction rule for delirium after electivenoncardiac surgery. JAMA1994;271:134-9
3. Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, van Gool WA: Delirium inelderly patients and the risk of postdischarge mortality, institutionalization, and dementia: ameta-analysis. JAMA2010;304:443-51
4. Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN: Cognitivetrajectories after postoperative delirium. N Engl J Med2012;367:30-9
5. Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK: One-year health care costsassociated with delirium in the elderly population. Arch Intern Med2008;168:27-32
6. Fong TG, Tulebaev SR, Inouye SK: Delirium in elderly adults: diagnosis, prevention and treatment.Nat Rev Neurol2009;5:210-20
7. Siddiqi N, House AO, Holmes JD: Occurrence and outcome of delirium in medical in-patients: asystematic literature review. Age Ageing2006;35:350-64
8. Chaput AJ, Bryson GL: Postoperative delirium: risk factors and management: continuingprofessional development. Can J Anaesth2012;59:304-20
9. Skrobik Y: Delirium prevention and treatment. Anesthesiol Clin2011;29:721-7
10. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ,Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses ofstudies that evaluate healthcare interventions: explanation and elaboration. BMJ2009;339: b2700
11. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews andmeta-analyses: the PRISMA statement. BMJ2009;339
12. Steiner LA: Postoperative delirium. part2: detection, prevention and treatment. Eur J Anaesthesiol2011;28:723-32
13. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessingthe quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials1996;17:1-12
14. Mangnall LT, Gallagher R, Stein-Parbury J: Postoperative delirium after colorectal surgery in olderpatients. Am J Crit Care2011;20:45-55
15. Whitlock EL, Vannucci A, Avidan MS: Postoperative delirium. Minerva Anestesiol2011;77:448-56
16. Allen SR, Frankel HL: Postoperative complications: delirium. Surg Clin North Am2012;92:409-31, x
17. Berggren D, Gustafson Y, Eriksson B, Bucht G, Hansson LI, Reiz S, Winblad B: Postoperativeconfusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg1987;66:497-504
18. Schindler BA, Shook J, Schwartz GM: Beneficial effects of psychiatric intervention on recoveryafter coronary artery bypass graft surgery. Gen Hosp Psychiatry1989;11:358-64
19. Williams-Russo P, Urquhart BL, Sharrock NE, Charlson ME: Post-operative delirium: predictorsand prognosis in elderly orthopedic patients. J Am Geriatr Soc1992;40:759-67
20. Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME: Cognitive effects afterepidural vs general anesthesia in older adults. A randomized trial. JAMA1995;274:44-50
21. Kim KY, McCartney JR, Kaye W, Boland RJ, Niaura R: The effect of cimetidine and ranitidine oncognitive function in postoperative cardiac surgical patients. Int J Psychiatry Med1996;26:295-307
22. Kaneko T: Prophylactic Consecutive Administration of Haloperidol Can Reduce the Occurrence ofPostoperative Delirium in Gastrointestinal Surgery. Yonago Acta medica1999;42:179-184
23. Williams-Russo P, Sharrock NE, Mattis S, Liguori GA, Mancuso C, Peterson MG, Hollenberg J,Ranawat C, Salvati E, Sculco T: Randomized trial of hypotensive epidural anesthesia in older adults.Anesthesiology1999;91:926-35
24. Mann C, Pouzeratte Y, Boccara G, Peccoux C, Vergne C, Brunat G, Domergue J, Millat B, ColsonP: Comparison of intravenous or epidural patient-controlled analgesia in the elderly after majorabdominal surgery. Anesthesiology2000;92:433-41
25. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM: Reducing delirium after hip fracture: arandomized trial. J Am Geriatr Soc2001;49:516-22
26. Aizawa K, Kanai T, Saikawa Y, Takabayashi T, Kawano Y, Miyazawa N, Yamamoto T: A novelapproach to the prevention of postoperative delirium in the elderly after gastrointestinal surgery. SurgToday2002;32:310-4
27. Kudoh A, Takase H, Takazawa T: A comparison of anesthetic quality in propofol-spinal anesthesiaand propofol-fentanyl anesthesia for total knee arthroplasty in elderly patients. J Clin Anesth2004;16:405-10
28. Nishikawa K, Nakayama M, Omote K, Namiki A: Recovery characteristics and post-operativedelirium after long-duration laparoscope-assisted surgery in elderly patients: propofol-based vs.sevoflurane-based anesthesia. Acta Anaesthesiol Scand2004;48:162-8
29. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P,van Gool WA: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: arandomized placebo-controlled study. J Am Geriatr Soc2005;53:1658-66
30. Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R: Donepezil in the prevention and treatment ofpost-surgical delirium. Am J Geriatr Psychiatry2005;13:1100-6
31. Papaioannou A, Fraidakis O, Michaloudis D, Balalis C, Askitopoulou H: The impact of the type ofanaesthesia on cognitive status and delirium during the first postoperative days in elderly patients. Eur JAnaesthesiol2005;22:492-9
32. Beaussier M, Weickmans H, Parc Y, Delpierre E, Camus Y, Funck-Brentano C, Schiffer E, Delva E,Lienhart A: Postoperative analgesia and recovery course after major colorectal surgery in elderlypatients: a randomized comparison between intrathecal morphine and intravenous PCA morphine. RegAnesth Pain Med2006;31:531-8
33. Leung JM, Sands LP, Rico M, Petersen KL, Rowbotham MC, Dahl JB, Ames C, Chou D,Weinstein P: Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients.Neurology2006;67:1251-3
34. Leung JM, Sands LP, Vaurio LE, Wang Y: Nitrous oxide does not change the incidence ofpostoperative delirium or cognitive decline in elderly surgical patients. Br J Anaesth2006;96:754-60
35. Lundstrom M, Olofsson B, Stenvall M, Karlsson S, Nyberg L, Englund U, Borssen B, Svensson O,Gustafson Y: Postoperative delirium in old patients with femoral neck fracture: a randomizedintervention study. Aging Clin Exp Res2007;19:178-86
36. Prakanrattana U, Prapaitrakool S: Efficacy of risperidone for prevention of postoperative deliriumin cardiac surgery. Anaesth Intensive Care2007;35:714-9
37. Sampson EL, Raven PR, Ndhlovu PN, Vallance A, Garlick N, Watts J, Blanchard MR, Bruce A,Blizard R, Ritchie CW: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride(Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int JGeriatr Psychiatry2007;22:343-9
38. Taguchi T, Yano M, Kido Y: Influence of bright light therapy on postoperative patients: a pilotstudy. Intensive Crit Care Nurs2007;23:289-97
39. Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, Filipovic M,Seeberger MD, Pargger H, Siegemund M, Carrel T, Seiler WO, Berres M, Strebel SP, Monsch AU,Steiner LA: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoingelective cardiac surgery--a randomized controlled trial. Crit Care Med2009;37:1762-8
40. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Byrne AJ, Hudetz AG, Warltier DC, Pagel PS:Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac VascAnesth2009;23:651-7
41. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA: Dexmedetomidine andthe reduction of postoperative delirium after cardiac surgery. Psychosomatics2009;50:206-17
42. McCaffrey R: The effect of music on acute confusion in older adults after hip or knee surgery. ApplNurs Res2009;22:107-12
43. Mouzopoulos G, Vasiliadis G, Lasanianos N, Nikolaras G, Morakis E, Kaminaris M: Fascia iliacablock prophylaxis for hip fracture patients at risk for delirium: a randomized placebo-controlled study. JOrthop Traumatol2009;10:127-33
44. Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J: Prevalence ofdelirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: arandomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study).Anesthesiology2009;111:1075-84
45. Larsen KA, Kelly SE, Stern TA, Bode RH, Jr., Price LL, Hunter DJ, Gulczynski D, Bierbaum BE,Sweeney GA, Hoikala KA, Cotter JJ, Potter AW: Administration of olanzapine to prevent postoperativedelirium in elderly joint-replacement patients: a randomized, controlled trial. Psychosomatics2010;51:409-18
46. Rubino AS, Onorati F, Caroleo S, Galato E, Nucera S, Amantea B, Santini F, Renzulli A: Impact ofclonidine administration on delirium and related respiratory weaning after surgical correction of acutetype-A aortic dissection: results of a pilot study. Interact Cardiovasc Thorac Surg2010;10:58-62
47. Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, Mears SC: Sedationdepth during spinal anesthesia and the development of postoperative delirium in elderly patientsundergoing hip fracture repair. Mayo Clin Proc2010;85:18-26
48. Marcantonio ER, Palihnich K, Appleton P, Davis RB: Pilot randomized trial of donepezilhydrochloride for delirium after hip fracture. J Am Geriatr Soc2011;59Suppl2: S282-8
49. Ono H, Taguchi T, Kido Y, Fujino Y, Doki Y: The usefulness of bright light therapy for patientsafter oesophagectomy. Intensive Crit Care Nurs2011;27:158-66
50. Pesonen A, Suojaranta-Ylinen R, Hammaren E, Kontinen VK, Raivio P, Tarkkila P, Rosenberg PH:Pregabalin has an opioid-sparing effect in elderly patients after cardiac surgery: a randomizedplacebo-controlled trial. Br J Anaesth2011;106:873-81
51. Royse CF, Andrews DT, Newman SN, Stygall J, Williams Z, Pang J, Royse AG: The influence ofpropofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary arterybypass surgery. Anaesthesia2011;66:455-64
52. Hakim SM, Othman AI, Naoum DO: Early Treatment with Risperidone for SubsyndromalDelirium after On-pump Cardiac Surgery in the Elderly: A Randomized Trial. Anesthesiology2012;116:987-97
53. Musclow SL, Bowers T, Vo H, Glube M, Nguyen T: Long-acting morphine following hip or kneereplacement: a randomized, double-blind and placebo-controlled trial. Pain Res Manag2012;17:83-8
54. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN: Haloperidolprophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomizedcontrolled trial*. Crit Care Med2012;40:731-9
55. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME: A predictive model for delirium inhospitalized elderly medical patients based on admission characteristics. Ann Intern Med1993;119:474-81
56. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons.Predictive model and interrelationship with baseline vulnerability. JAMA1996;275:852-7
57. Wells GA, Sultan SA, Chen L, Khan M, D C: Indirect treatment comparison [computer program].Version2.0. Ottawa: Canadian Agency for Drugs and Technologies in Health Available from:http://cadth.ca/en/resources/about-this-guide/download-software2009
58. Lin YY, He B, Chen J, Wang ZN: Can dexmedetomidine be a safe and efficacious sedative agent inpost-cardiac surgery patients? a meta-analysis. Crit Care2012;16: R169
59. Lin Y, Chen J, Wang Z: Meta-analysis of factors which influence delirium following cardiacsurgery. J Card Surg2012;27:481-92
60. Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adultpatients: a meta-analysis. Intensive Care Med2010;36:926-39
61. Devlin JW, Skrobik Y: Antipsychotics for the Prevention and Treatment of Delirium in theIntensive Care Unit: What Is Their Role? Harvard Review of Psychiatry2011;19:59-67
62. Lonergan E, Britton AM, Luxenberg J, Wyller T: Antipsychotics for delirium. Cochrane DatabaseSyst Rev2007: CD005594
63. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E: Efficacyand safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized,double-blind, placebo-controlled pilot study. Crit Care Med2010;38:419-27
64. Devlin J, Skrobik Y, Riker R, Hinderleider E, Roberts R, Fong J, Ruthazer R, Hill N, Garpestad E:Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients withdelirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Crit Care2011;15: R215
65. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: treating delirium ina critical care setting. Intensive Care Med2004;30:444-9
66. Campbell N, Boustani MA, Ayub A, Fox GC, Munger SL, Ott C, Guzman O, Farber M,Ademuyiwa A, Singh R: Pharmacological management of delirium in hospitalized adults--a systematicevidence review. J Gen Intern Med2009;24:848-53
67. Devlin JW, Al-Qadhee NS, Skrobik Y: Pharmacologic prevention and treatment of delirium incritically ill and non-critically ill hospitalised patients: a review of data from prospective, randomisedstudies. Best Pract Res Clin Anaesthesiol2012;26:289-309
68. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S,Lund S, Jacobson P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatmentof delirium in hospitalized AIDS patients. Am J Psychiatry1996;153:231-7
69. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium.Psychosomatics2004;45:297-301
70. Grover S, Kumar V, Chakrabarti S: Comparative efficacy study of haloperidol, olanzapine andrisperidone in delirium. J Psychosom Res2011;71:277-81
71. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT,Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW, Investigators MT: Feasibility,efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized,placebo-controlled trial. Crit Care Med2010;38:428-37
72. O'Mahony R, Murthy L, Akunne A, Young J, Guideline Development G: Synopsis of the NationalInstitute for Health and Clinical Excellence guideline for prevention of delirium. Ann Intern Med2011;154:746-51
73. Popp J, Arlt S: Prevention and treatment options for postoperative delirium in the elderly. CurrOpin Psychiatry2012;25:515-21
74. Deschodt M, Braes T, Flamaing J, Detroyer E, Broos P, Haentjens P, Boonen S, Milisen K:Preventing delirium in older adults with recent hip fracture through multidisciplinary geriatricconsultation. J Am Geriatr Soc2012;60:733-9
75. Mouchoux C, Rippert P, Duclos A, Fassier T, Bonnefoy M, Comte B, Heitz D, Colin C,Krolak-Salmon P: Impact of a multifaceted program to prevent postoperative delirium in the elderly: theCONFUCIUS stepped wedge protocol. BMC Geriatr2011;11:25
76. Saltvedt I, Prestmo A, Einarsen E, Johnsen LG, Helbostad JL, Sletvold O: Development anddelivery of patient treatment in the Trondheim Hip Fracture Trial. A new geriatric in-hospital pathwayfor elderly patients with hip fracture. BMC Res Notes2012;5:355
77. Wyller TB, Watne LO, Torbergsen A, Engedal K, Frihagen F, Juliebo V, Saltvedt I, Skovlund E,Raeder J, Conroy S: The effect of a pre-and post-operative orthogeriatric service on cognitive functionin patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial. BMC Geriatr2012;12:36
78. Edelstein DM, Aharonoff GB, Karp A, Capla EL, Zuckerman JD, Koval KJ: Effect ofpostoperative delirium on outcome after hip fracture. Clin Orthop Relat Res2004:195-200
79. Gonzalez M, Martinez G, Calderon J, Villarroel L, Yuri F, Rojas C, Jeria A, Valdivia G, Marin PP,Carrasco M: Impact of delirium on short-term mortality in elderly inpatients: a prospective cohort study.Psychosomatics2009;50:234-8
80. Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M: Postoperative delirium inthe elderly: risk factors and outcomes. Ann Surg2009;249:173-8
81. Boustani MA, Campbell NL, Khan BA, Abernathy G, Zawahiri M, Campbell T, Tricker J, Hui SL,Buckley JD, Perkins AJ, Farber MO, Callahan CM: Enhancing care for hospitalized older adults withcognitive impairment: a randomized controlled trial. J Gen Intern Med2012;27:561-7
82. Stenvall M, Berggren M, Lundstrom M, Gustafson Y, Olofsson B: A multidisciplinary interventionprogram improved the outcome after hip fracture for people with dementia--subgroup analyses of arandomized controlled trial. Arch Gerontol Geriatr2012;54: e284-9
83. Holtta E, Laakkonen ML, Laurila JV, Strandberg TE, Tilvis R, Kautiainen H, Pitkala KH: Theoverlap of delirium with neuropsychiatric symptoms among patients with dementia. Am J GeriatrPsychiatry2011;19:1034-41
84. Landreville P, Voyer P, Carmichael PH: Relationship between delirium and behavioral symptomsof dementia. Int Psychogeriatr2013;25:635-43
85. Silverstein JH, Deiner SG: Perioperative delirium and its relationship to dementia. ProgNeuropsychopharmacol Biol Psychiatry2012;43C:108-115
86. Steiner LA: Postoperative delirium. Part1: pathophysiology and risk factors. Eur J Anaesthesiol2011;28:628-36
87. Robinson TN, Raeburn CD, Tran ZV, Brenner LA, Moss M: Motor subtypes of postoperativedelirium in older adults. Arch Surg2011;146:295-300